Browse by Poster Track

Type here to filter the list

Bioanalytics
W1030-04-028 - A Platform Technology For The Rapid Generation Of Robust Anti-Idiotypic Binders For Clinical PK Assays

Favorite
W1130-04-028 - A Diagnostic Tool for Red Blood Cell Disorders - Chipcytometry as a New RBC Analysis Platform

Favorite
M1130-04-025 - A Fit for Purpose Validation of a Single Plate Assay for the Quantification of Total and Bound Cytokine

Favorite
T1030-03-021 - A Gyros Multiplex Bioanalytical Strategy for Monitoring a Fusion Fc-Peptide Biotransformation In Vivo

Favorite
M0930-03-021 - A Hybrid IC-LC-MS/MS Approach to the Quantification of CD154 from Plasma

Favorite
T0930-03-017 - A Hybrid LBA/LC-MS Assay for Multiplex Quantitation of Insulin Analogs in Plasma

Favorite
T1330-04-025 - A LC-MS/MS Method for Quantitation of Temozolomide in Mice Brain following Intra Cerebral Brain Micro-dialysis

Favorite
T1030-04-029 - A Middle-Down Analytical Strategy for Determination of Mature Growth Differentiation Factor-15 (GDF-15) in Human Serum Using Immunoaffinity Enrichment – Liquid Chromatography/Tandem Mass Spectrometry

Favorite
T0930-03-021 - A Multiplex Bead-Based Immunoassay (Luminex) for the Analysis of Inflammatory Cytokines in Mouse Serum

Favorite
M0930-04-027 - A New Immunoaffinity Extraction Method for Rapid Diagnosis of Paralytic Shellfish Poisoning in Humans

Favorite
M1230-03-020 - A Novel and Sensitive UPLC-MS/MS Method for the Determination of Mequitazine in Rat Plasma and Urine

Favorite
M1130-03-020 - A Novel Immunoassay for Assessment of Specific Anti-Drug IgE Antibodies

Favorite
M1330-03-023 - A Novel Lispro ELISA for Specific Determination of the Rapid-Acting Insulin Analog, Insulin Lispro, in Human Samples

Favorite
M1130-03-017 - A Novel Robust Approach to Detect Treatment-Boosted Anti-Drug Antibodies (ADA) in a Study Population with Pre-Existing ADA

Favorite
T1430-04-028 - A pH-sensitive Liposome Approach to Target the Survivin Protein: Overcoming Cancer Chemoresistance in Retinoblastoma

Favorite
T1330-03-018 - A Rapid and Selective Method for 5-Azacytidine in Rat Plasma, Lung, Brain, and Liver Using LC-MS/MS

Favorite
M1430-03-022 - A Sensitive Enantioselective LC-MS/MS Method for the Determination of Dasotraline in Human Plasma and Its Application to Clinical Development

Favorite
W1130-03-020 - A Sensitive Liquid Chromatography-Mass Spectrometry Method for Detection of Usnic Acid in Rat Plasma and Its Application to Pharmacokinetic Study of Transdermal Administration

Favorite
M1530-03-017 - A Sensitive Microflow LC/MS/MS Method for the Analysis of Fluticasone Propionate in Human Plasma

Favorite
M1330-04-028 - A Simplified and Automated LC-MS/MS Method to Determine of 25-OH-Vitamin D2/D3 in Human Serum Using Strata RP Online Extraction Column

Favorite
W1130-03-021 - A Targeting Theranostics Nanomedicine for Real-Time Monitoring Drug-Release

Favorite
T1330-03-017 - A UPLC-MS/MS Method for the Simultaneous Determination of Diethyl Phthalate and Its Metabolite, Monoethyl Phthalate, in Rat Plasma, Urine, and Various Tissues Collected from a Toxicokinetic Study

Favorite
M1330-03-017 - Absolute Quantitation of Biotherapeutic Drug Product and Endogenous Protein in Human Serum Using a Hybrid Immunoassay-LC/MS Approach

Favorite
T0930-04-029 - Absolute Quantitation of Five Antibody Drug Products in Dosed Monkey Serum, CSF and Brain Lysate for Lead Candidate Identification Using LC-MRM/MS

Favorite
T0930-03-018 - ADC PK Profiling Strategies on LC-MS Platforms: Top-Down, Bottom-Up, and Multiplexing

Favorite
M1530-03-020 - Advances in Approval of Topical Dermatological Generic Drug Products Pertinence of New FDA Drafted Guidance on Acyclovir Cream-IVRT/IVPT

Favorite
W0930-03-020 - Aegyris™ – The Simple and Efficient Software Solution for the Validation of Immunogenicity Assays to Support Vaccine Clinical Trials

Favorite
W1130-04-025 - An LC-MRM/MS-Based PD Assay for Monitoring Site Occupancy of an Oncogene Protein in Tumor Xenograft Tissue from Mice Dosed with Alkylating Agent

Favorite
T1030-04-028 - Analysis of Anamorelin Stereoisomers in Human Plasma Using Coupled Achiral / Chiral HPLC with Tandem Mass Spectroscopy Detection

Favorite
M1330-04-027 - Analysis of Arachidonic Acid as a Biomarker in Human Plasma Using LC-MS/MS for Clinical Studies

Favorite
W1230-04-025 - Analytical Challenges in Quantitation of Nanoparticle Encapsulated Material

Favorite
T1030-04-026 - Analytical Comparability Strategies for Rituximab and Its Biosimilar

Favorite
W1230-03-021 - Analytical Method for the Quantification of Magnesium Ascorbyl Phosphate (MAP) in Isotonic Normal Saline with Ion-Pair Chromatography

Favorite
W0930-03-018 - Anti-Drug Antibody Data Management Using E-Workbook

Favorite
T0930-04-028 - Application of Multivariate Analysis of FTIR and CD Spectroscopy Data to Differentiates Structural Perturbations in Proteins

Favorite
W0930-04-025 - Application of Taylor Dispersion to the Particle Size Characterization of mRNA and mRNA-loaded Lipid Nanoparticles

Favorite
T1530-04-025 - Application of the Multi-Attribute Method (MAM) in Lot-to-Lot Comparison of Rituximab Drug Product

Favorite
M1430-04-026 - Assessing the Predictive Response of a Simple and Sensitive Blood-Based Biomarker between Estrogen-Negative Solid Tumors

Favorite
M1130-04-027 - Association of Salivary Biomarkers with Skeletal Maturation in Orthodontic Patients

Favorite
M1130-04-029 - Automated Analysis of Melanoma Gene Expression Patterns by Sequential Interrogation of Variable RNA Average Count-space

Favorite
W1230-03-017 - Automated High-Throughput Sample Preparation of Insulin-Like Growth Factor 1 for Targeted LC-MS/MS Quantification

Favorite
T1430-04-027 - Bacteria and Human Cells-Mediated Synthesis of Biogenic Metallic Nanoparticles. A Nanometric Trojan Horse Approach

Favorite
M1330-04-029 - Bioanalysis of Plasma Amino Acids as Potential Biomarkers of NSAIDs-Induced Gastric Injury by Liquid Chromatography-Tandem Mass Spectrometry

Favorite
T1030-04-027 - Cannabis for Medical Purposes: Simultaneous Quantification of 11 Cannabinoids in Cannabis by UPLC-UV

Favorite
M1430-03-020 - Case Study to Address Matrix Interference in a PK Assay: Serum versus Plasma

Favorite
T1530-03-020 - Challenges of Cross-Lab Validation for Sphingolipids Biomarker Assays with Multiple Isomers in Human Dried Blood Spots

Favorite
W1030-03-017 - Characterization of Exosomes Derived from Cancer Resistant Cells as a Drug Delivery Carrier

Favorite
M1530-04-028 - Characterization of Two Kinase-Modulating Compounds in Tumor Infiltrating Lymphocytes (TILs) Using Flow Cytometry and Meso Scale Discovery

Favorite
M1030-03-019 - Co-delivery of Doxorubicin and Erlotinib by Dual Functionalized Liposomes on Glioblastoma Tumor Regression Using an In Vitro Brain Tumor Model

Favorite
T1430-03-020 - Comparability, Similarity, Linearity and High Order Structure Analysis of an IgG1 Sample by Microfluidic Modulation Spectroscopy

Favorite
M1130-03-018 - Controlling Effects of IgG4 Hybrid Antibody Formation in Bridging Immunogenicity Assays

Favorite
M1030-04-029 - Detection and Identification of New Protein Features Using Multi-attribute Monitoring (MAM) as Part of Mass Spectrometry-Based Quality Control (QC)

Favorite
M0930-04-026 - Determination of Triazolam and Its Two Major Metabolites in Mouse In Vivo Using SFC Coupled with Mass Spectrometry

Favorite
T1430-04-026 - Developing and Qualifying the Anti-drug Antibody (ADA) Assay for a Bispecific Nanobody by Electrochemiluminescence (ECL) Immunoassay

Favorite
W1030-03-018 - Development and Assessment of Novel Fluorescent Hyaluronic Acid Nano-Particulate System for Biomedical Applications in Bio-Imaging, Drug Delivery, and Bio-Sensing

Favorite
W1030-04-029 - Development and Characterization of Mouse Th17-Related and Cytokine Multiplex V-PLEX® Assays

Favorite
T1530-04-029 - Development and Implementation of a Rapid Generic Ig Dip and Read Ligand Binding Assay Format on the Octet RED 384™ for the Quantitation of Human IgG in Mouse Plasma

Favorite
M0930-04-030 - Development and Optimization of a Liquid Chromatography Tandem Mass Spectrometry Method for Quantification of Bevacizumab and Ranibizumab in Human Plasma after Intravitreal Administration

Favorite
M1030-03-022 - Development and Proof-of-Concept of a New Flow-through System for High Resolution NMR to Evaluate Biologics-Producing Cell Lines and Their Growth Environments

Favorite
T1530-03-019 - Development and Validation of a Human Total Soluble OX40 Biomarker Assay for use on Clinical Studies

Favorite
W1130-03-022 - Development and Validation of a LC-MS/MS Method for the Determination of Perampanel in Human Plasma

Favorite
W1130-03-019 - Development and Validation of a UPLC-MS/MS Method and Comparison with an HPLC-UV Method for Simultaneous Determination of cis-, trans-cefprozil Isomer in Human Plasma

Favorite
T1230-03-019 - Development and Validation of an ELISA Method for the Determination of Anti-Polyethylene Glycol (PEG) Antibodies in Human Serum

Favorite
M1430-03-019 - Development and Validation of an Immunoassay for Total Therapeutic Antibody (RO7112689; SKY59) Quantification in the Presence of C5 and that for Total C5 Quantification in Cynomolgus Monkey Plasma

Favorite
M1330-03-019 - Development and Validation of LC-MS/MS Assay for 5-Amino-1-Methyl Quinolinium in Rat Plasma

Favorite
M1230-03-018 - Development and Validation of LC-MS/MS Assay for Simultaneous Analysis of Simvastatin, Atorvastatin, Rosuvastatin and Their Active Metabolites in Plasma of Obese Subjects Underwent Bariatric Surgery

Favorite
M0930-03-022 - Development and Validation of Robust Analytical Method to Quantify rhSOD3 from Mouse Plasma via HPLC-MS/MS

Favorite
T1330-04-027 - Development of a Simple and Sensitive LC-MS/MS Method for the Determination of Tramadol and Its Metabolites in Human Plasma

Favorite
T1130-04-025 - Development of a Ultra-Sensitive Digital Immunoassay for Human Soluble HLA-E Biomarker

Favorite
M1130-03-022 - Development of an Anti-Drug Antibody Assay with High Drug Tolerance for Bevacizumab (Avastin®) and Its Biosimilars

Favorite
T1030-03-019 - Development of an HPLC Method for Simultaneous Detection of Pterostilbene and Its Metabolites

Favorite
M0930-03-018 - Development of an Immunoaffinity-LC-MS/MS Bioanalytical Method for the Highly Sensitive Quantification of Active Infliximab and Adalimumab

Favorite
T1330-03-021 - Development of an LC-MS/MS Method for Determining Methylsulfonylmethane (MSM) Pharmacokinetics in Humans

Favorite
M1430-03-017 - Development of an LC-MS/MS Method for Quantification of Cytarabine in Rat Plasma

Favorite
W1230-03-018 - Development of an Ultra-Sensitive Biomarker Assay for Megakaryocyte Potentiating Factor

Favorite
M1030-03-017 - Development of Antibodies and PK and ADA Assays for a Cysteine Knot Fusion Protein

Favorite
M1430-03-024 - Development of High Sensitivity and Specificity LC-MS/MS Method to Evaluate Peptide Permeability across Cell Monolayer

Favorite
T0930-03-022 - Development of NISTmAb-derived homogeneous antibody-drug conjugate (ADC) standards

Favorite
M0930-04-029 - Development of Novel Mass Spectrometry Methods for the Determination of Drug to Antibody Ratio of Interchain Cysteine Linked Antibody Drug Conjugates(ADC)

Favorite
M1330-03-024 - Diagnosing and Solving Phospholipid-Based Matrix Effects in LC-MS Bioanalysis

Favorite
T1030-03-017 - Discovery of Antibacterial Properties of Pyrimidine Derivatives by High Throughput Screening of Pre-metabolized Chemical Library

Favorite
T1130-03-018 - Dual Functionalized Liposomes for Co-delivery of Anti-cancer Chemotherapeutics to Brain Tumor

Favorite
T1130-04-030 - Echinacea purpurea as an Herbal Adjuvant for Vaccine-Based Cancer Therapy

Favorite
T1230-03-021 - Effector and Regulatory T Cell Epitope Content, and not Humanization nor Biophysical Properties, is Predictive of Antibody Immunogenicity

Favorite
M1430-03-023 - Efficient and Economical Preclinical Pharmacokinetic Analyses for Human Therapeutic Antibodies and Constructs, Using a Validated Human Immunoglobulin Immunoassay in Plasma of Mice, Rats, and Monkeys

Favorite
T1230-04-025 - EGFR Transactivation by Endothelin Receptor Involves a Src Activated Pro-HBEGF Cleavage in Asthmatic Airway Smooth Muscle (ASM) Cells

Favorite
T1130-04-031 - Enhancing the Antitumor Activity of Adenovirus Vaccines by Combining with Intratumoral Delivery of CpG-loaded Nanoparticles.

Favorite
M1030-04-028 - Evaluating Platelet Reactivity via Laser Defraction Particle Analysis

Favorite
M1430-03-018 - Evaluation of an ELISA Method Using Novel Amplification Reagent and Its Comparison with Traditional Colorimetric ELISA Assay for the Measurement of Aflibercept in Biological Matrices

Favorite
W0930-04-027 - Evaluation of Generic PK Assay: Comparison between ELISA and Ella Platform

Favorite
T1430-04-025 - Evaluation of the Subcellular Uptake and Distribution of Gemini Surfactant Gene Delivery Nanoparticles Using Mass Spectrometry

Favorite
W1130-04-026 - Fit-for-Purpose GLP Validation of an Intra-Cellular Cytokine Staining Assay

Favorite
T1230-04-029 - Fit-for-Purpose Validation for the Measurement of 29 Cytokines in Human Plasma by MesoScale

Favorite
W0930-04-029 - Functional Bioassay Miniaturization is Enhanced by Using Acoustic Liquid Handling for Antibody Transfer

Favorite
M1430-04-027 - Galactose Single Point Test as a Safe, Simple, Highly-Sensitive Quantitative Liver Function Assessment in Patients with Non-alcoholic Fatty Liver Disease

Favorite
T1230-04-028 - Glycogen Synthase as Biomarker for Neurodegenerative Lafora Disease

Favorite
W1230-04-026 - Green Synthesis of a Synergetic Structure of Tellurium Nanowires and Metallic Nanoparticles for Biomedical Applications

Favorite
T1230-03-022 - HLA DR-binding Assays as a Tool for Immunogenicity Screening: Developing the Best Practices for Determining Immunogenicity

Favorite
T1530-04-027 - How Does Hydroxypropyl-ß-cyclodextrins Inhibit Human Growth Hormone Aggregation?

Favorite
W1230-03-019 - HSP47 Immunoassay Validation and Application to Analysis of Normal and Disease Samples

Favorite
T1130-04-026 - Image Cytometry: A New Method for Deep Phenotyping of Rare Cells in the Blood of Oncology Patients

Favorite
W0930-03-017 - Impact of Critical Reagents Characterization and Handling on Anti-Drug Antibodies (ADA) Assay Method Development: A Case Study for a Humanized Monoclonal IgG ADA Assay

Favorite
W1030-03-022 - Improved Acceptance Criteria for Laboratory Developed Flow Cytometry Tests

Favorite
T1530-03-017 - Improved Sample Processing to Optimize Stability for Total Glutathione Determination in Human Plasma Using a Fit-for-Purpose Approach

Favorite
T1230-03-020 - Improving Drug Tolerance by Going Back to the Basics

Favorite
T1030-03-020 - In Vivo Assessment of Multiple Quality Attributes of Protein Therapeutics and Their Biological Relevance by High Resolution Liquid Chromatography Mass Spectrometry and Multiplexed Proteomics Approach

Favorite
T0930-04-027 - Influence of Chitosan Coating on the Oral Bioavailability of Gold Nanoparticles in Rats

Favorite
T0930-03-020 - Inhibition on Esterase Mediated Hydrolysis of Simvastatin in Rat Blood and the Impact on iIs Pharmacokinetics in Rats

Favorite
T1330-03-019 - LC/MS/MS Method for the Quantification of Metronidazole in Skin Dialysate

Favorite
W1130-03-017 - LC-MS Method Development of Midazolam and Ketamine: Application to a Pharmacokinetic Study in Patients on Extracorporeal Membrane Oxygenation Therapy

Favorite
M1430-04-025 - LC-MS/MS Method for Quantitative Tissue Distribution Analysis (QTDA) of Targeted Metabolomics

Favorite
M1130-04-026 - LC-MS/MS Method for the Quantification of 3,4-Dihydroxyphenylglycol (DHPG), a Biomarker for MAO-A Inhibition

Favorite
M1330-04-025 - LC-MS/MS Method for the Quantification of OAT1 Biomarkers

Favorite
M1230-04-025 - Liver metabolomics in Mice with Erythropoietic Protoporphyria

Favorite
W1030-03-021 - Lot-to-lot Comparison and Long-term Stability of the IDS-iSYS Growth Hormone and Insulin-like Growth Factor-1 Immunoassays for Clinical Trial Support

Favorite
T1130-04-027 - Measurement of Protein X by LC-MRM/MS Using the AQUA Approach in Dissected FFPE Breast and Gastric Tumor Tissue

Favorite
M1330-03-018 - Measurement of Squalene in Human Plasma by UPLC-APCI-MS/MS

Favorite
T1030-03-018 - Metabolite Profiling of Ceftibuten and Clavulanate following Individual and Combined Oral Administration to Healthy Subjects to Evaluate Potential for Drug-Drug Interaction

Favorite
T1330-04-029 - Method Development for Bioanalysis of Efavirenz using HPLC-MS

Favorite
T1130-03-022 - Method Performance Assessment during Clinical Development to Support Robust Method Development for Late Stage Biologics Programs

Favorite
M1130-04-028 - Method Validation of Quantitation IL-17A in Human Serum Using the Ultrasensitive Quanterix Simoa™ Platform

Favorite
M1130-03-019 - Mitigation of Non-Specific Binding of Master Mix Reagents in a CDX-301 Anti-Drug Antibody Assay

Favorite
T0930-04-030 - Modern LC-MS/MS-based proteomics: Powerful tools for reliable discovery of biomarkers and biomedical mechanisms in drug development

Favorite
W1030-04-025 - Multifactorial Troubleshooting and Corrective Action for the Use of Hamilton Automation in Preparation of Plate Acceptance Quality Control Samples in Non-Clinical and Clinical PK Method Development

Favorite
T1430-03-021 - Neurite outgrowth from PC12 cells in presence of nanoparticle covered carbon nanotubes: potential to develop a novel nanoparticle based therapeutic approach?

Favorite
M1530-04-025 - New Immunoassay Platforms: A Practical Guide to Method Validation

Favorite
T1430-03-017 - Non-arrhenius Behavior of Peptide Fibril Formation in the Presence of Stabilizing Excipients and Its Impact on Formulation Development

Favorite
W1230-04-027 - Optimization and Development of an Oligonucleotide Hybridization ELISA for the Quantitative Detection of a Therapeutic Aptamer in Human Plasma

Favorite
M1130-03-021 - Optimization of Sensitivity and Drug Tolerance in a CDX-1140 Anti-Drug Antibody Assay Using Split-Plot Design of Experiment.

Favorite
M0930-03-017 - Optimized Extraction and MFLC-MS/MS Analysis of the Antibody Drug Conjugate SigmaMAb Extracted from Rat Plasma

Favorite
T1130-04-029 - Overcoming Challenges in ADA Assay Development

Favorite
W0930-04-026 - Overcoming Matrix Effect: Development and Validation of an LC-MSMS Assay for the Quantitation of a Clinical-Stage Monoclonal Antibody (mAb) in Human Urine

Favorite
W1230-04-028 - Passive Permeability of the Blood-Brain Barrier to [13C]Sucrose Compared in Young Male and Female Mice

Favorite
M1530-04-026 - Patient-Specific Fluorescence Aberration Profiles During Longitudinal Clinical Trials

Favorite
W1130-04-029 - PD-1-Positive Population in Resting T Cells Identified Using a Qualified Flow Cytometric Method

Favorite
T1030-04-025 - Peptide Mimetics for Pharmacokinetic Analysis of Monoclonal Antibody Therapeutics

Favorite
T1330-04-028 - PHARMACOKINETICS OF NOVEL ORGANIC CARBON MONOXIDE PRODRUG BW-CO-103

Favorite
M1030-03-018 - Photo-curable Hyaluronic Acid Hydrogels for Encapsulation and Tissue Engineering of Human Dental Pulp Stem Cells

Favorite
T1130-03-023 - Potency Assessment of an Antibody Drug Conjugate Using a Dual Approach: Measurement of Specific Binding of Antibody Component and Cytotoxic Efficacy of Drug Conjugate

Favorite
T1130-04-028 - Preclinical Immunogenicity Assessment of Therapeutic Proteins and Antibodies: Applications of a Novel ADA Assay Platform based on Capillary Electrophoresis and Immunodetection

Favorite
T1130-03-017 - Preparation and Characterization of Poly(2-ethyl-2-oxazoline)-Lipid Conjugate as an Alternative to Polyethylene Glycol (PEG) for Surface Modified Long Circulating Liposomes

Favorite
T1130-03-019 - Preparation, Evaluation and In Vitro Characterization of a New 8-aminoquinoline Derivative Loaded Nanostructured Lipid Carriers and Nanoemulsion for Relapsing Malaria

Favorite
T1130-03-021 - Prevention of Cerebral Ischemia/Reperfusion Injury by Neutrophil-Derived Nanovesicles

Favorite
M1530-03-018 - Qualification of a Simultaneous Extraction of Ceftibuten and Clavulanate from Dog Plasma for Analysis by LC-MS/MS to Support Pharmacokinetic Studies

Favorite
W1130-04-027 - Qualification of an IFN-gamma Elispot Assay in the Bioanalytical Laboratory

Favorite
T0930-04-026 - Quantification a Phase II Metabolite in Dog Plasma without Reference Standard Material by LC/MS/MS

Favorite
M1230-03-019 - Quantification of Doxorubicin in Rabbit Liver Tumor Samples after Near Infrared Mediated Photochemotherapy Using HPLC Assay with Fluorescenc Detection

Favorite
W0930-03-021 - Quantification of human IgG in F12 fermentation medium without sample preparation using Flow induced dispersion analysis (FIDA)

Favorite
M1230-04-026 - Quantification of Intracellular Triphosphate Metabolites of Emtricitabine by LC-MS/MS.

Favorite
M1430-03-021 - Quantification of Zolpidem in Human Plasma Using LC-MS/MS

Favorite
T1030-04-030 - Quantitation and Metabolic Profiling of siRNA in Biological Matrices by Liquid Chromatography and High Resolution Accurate Mass (LC/MS-HRAM) Mass Spectrometry

Favorite
M1330-04-026 - Quantitation of 17-β-Estradiol using a very sensitive and high-throughput LC-MS/MS assay: Application to guinea pig pharmacokinetic study

Favorite
W1030-03-019 - Quantitation of Anti-Sense Oligonucleotides in Biological Samples Using a One-Step SPE Method and LC-MS/MS

Favorite
T1430-03-018 - Quantitation of Four Chiral Drug Compounds Simultaneously Using Normal Phase LC-MS/MS Equipped with an APPI Ion Source

Favorite
W0930-03-019 - Quantitation of the Monoclonal Antibody Rituximab Using Volumetric Absorptive Microsampling, Impact-Assisted Extraction, Trypsin Digestion and LC-MRM

Favorite
T1330-03-020 - Quantitative Raman Microanalysis of Drug and Lipid Accumulation in Pulmonary Alveolar Macrophages

Favorite
M1430-04-029 - Rapid LC-MS/MS Assay for CER1, an Essential Omega-O-acylceramide in Primary Human Keratinocytes

Favorite
T1230-03-018 - Redefining Distribution: Immunogenicity Screening Cut Point Determination via Shapiro-Wilk and Skewness

Favorite
W1030-04-026 - Remicade Stabilization with Hydroxypropyl-ß-Cyclodextrins

Favorite
M1530-03-019 - Selective Quantitation of 1,3-Propanediol in Dog Plasma Using Differential Ion Mobility Spectrometry

Favorite
T1330-04-026 - Sensitive LC-MS/MS method for determination of doxorubicin and its metabolite, doxorubicinol, in mouse plasma: Application to determination of new formulation of doxorubicin’s cardiotoxicity in mice

Favorite
M1430-04-028 - Serological Epidemiology of Cytomegalovirus in Pregnant Women Attending at Maternity Lucrécia Paim, Luanda, Angola

Favorite
T1230-04-027 - Seroprevalence of Rubella Virus in Pregnant Women Attending at Maternity Lucrécia Paim, Luanda, Angola

Favorite
T1030-03-022 - Simultaneous Determination of Dexmedetomidine and Its Two N-glucuronides in Adult Critically Ill Patients

Favorite
T0930-04-025 - Simultaneous Determination of Donepezil and Its Three Active Metabolites in Rat Plasma and Brain by LC-MS/MS

Favorite
M1230-04-027 - Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using LC/MS-MS

Favorite
T1530-03-018 - Singlicate Analysis: Should This Be the Default for Biomarker Measurements Using Ligand Binding Assays?

Favorite
M1030-04-027 - Slow Off-Rate Modified Aptamer (SOMAmer) as a Novel Reagent in Immunoassay Development for Accurate Soluble Glypican-3 Quantification in Clinical Samples

Favorite
M1130-04-030 - Smart Polymer Reagents for Bioanalytics and In Vitro Diagnostics

Favorite
M0930-04-025 - Specific Identification for Capto Family Chromatography Resins by FTIR and Particle Size Analysis

Favorite
M0930-03-019 - Specific Quantitation of Antisense Oligonucleotides in Plasma Using MSD® Electrochemiluminescence, Hybridization-Based ELISA, and HPLC-MS/MS Platforms

Favorite
T0930-03-019 - Stability of Diluted Neuromuscular Blocking Agents Utilized in Perioperative Hypersensitivity Evaluation

Favorite
T1430-03-022 - Study of Multi-Walled Carbon Nanotubes in Lung Tissue Using a Combined Hyperspectral Imaging Technique

Favorite
M1030-04-025 - Supporting Clinical Trials: The Impact of Sample Preparation on the Quality of Immunology Data

Favorite
M1030-03-020 - Surface Modification of Gemcitabine-Incorporated Acid-Sensitive Micelles Increases Their Cytotoxicity against Macrophages and Tumor Cells

Favorite
T1430-04-029 - Synthesis and Characterization of Tellurium Nanoparticles with Antimicrobial and Anticancer Properties made by Green Synthesis with Orange ,Lemon , and Lime Extract

Favorite
M1030-03-021 - Synthesis and Characterization of Temozolomide Loaded Oleic Acid Magnetic Nanoparticles for Treatment of Glioblastoma Multiforme

Favorite
W0930-03-022 - TANDEM UHPLC OPERATION FOR HIGH-THROUGHPUT LC-MS PEPTIDE MAPPING ANALYSES

Favorite
T1430-03-019 - The Determination of Human PBMC Counts Using a Genomic DNA Standard with Fluorescent Quantitation

Favorite
W1030-04-027 - The Elusive Labile Iron: Bioanalytical Techniques to Measure Iron Speciation in Human Plasma

Favorite
T1230-04-026 - Toxoplasmosis and Pregnancy in Luanda, Angola

Favorite
T1130-03-020 - Ultra Sensitive PK Bioanalysis in Support of the Development of a Bispecific Immune-Recruiting Biotherapeutic

Favorite
T1530-04-028 - Ultra-Sensitive Double Immunocapture-LC/MS Assay for Quantitation of a Therapeutic Protein in Monkey Plasma and Ocular Matrices

Favorite
T1530-04-026 - Understanding of Protein Adsorption to Interfaces Using Sum Frequency Generation Spectroscopy: Effects of Interfacial Interactions on Protein Conformation and Drug Product Stability

Favorite
M1230-03-017 - Use of Alternative Mobile Phase Additives to Improve Reverse Phase HPLC-MS/MS Sensitivity

Favorite
W0930-04-028 - Use Photo-Reactive Excipients to Detect Peptide-Matrix Interactions in Lyophilized Solid

Favorite
W1230-03-020 - Utilizing High-Content Human Protein Microarrays to Identify Potential Biomarkers for Hypertrophic Cardiomyopathy

Favorite
M1530-04-027 - Validation of a Research Use Only Flow Cytometric Assay for Clinical Diagnostic Implementation: HLA-DR Expression on Monocytes

Favorite
M0930-03-020 - Validation of an IC - LC-MS/MS Method for the Quantification of Insulin Aspart in Human Plasma and Serum

Favorite
Clinical Pharmacology
T1230-05-033 - A Comprehensive and Systematic Review of Gastric pH and Factors Affecting Gastric Fluid Volume Dynamics under Fasted and Fed Conditions in Humans

Favorite
M1030-05-036 - A First-Iin-Human Trial Comparing Pharmacokinetics, Pharmacodynamics and Safety of Cannabis Following Multiple, Ascending Doses of Dried Tablets Delivered by Smoking Inhalation

Favorite
M1330-05-034 - A Hybrid PBPK/PD Model for the Effect of Antibody Binding Site Barriers on Antibody Tumor Growth Inhibition in Preclinical Animal Studies

Favorite
M1430-05-039 - A Joint Model Describing Gastric Emptying Driven Pharmacokinetics of Losartan and Its Active Metabolite EXP-3174 Based on Data from Two Bioequivalence Studies

Favorite
M0930-05-034 - A Pharmacokinetic Evaluation of Dabigatran Etexilate, Total Dabigatran, and Unconjugated Dabigatran from Dabigatran Etexilate Mesylate Capsules in Healthy Subjects

Favorite
T1330-05-033 - A Pharmacokinetic Evaluation of Fluticasone Furoate Given Intranasally in Healthy Subjects Using an Ultra-Sensitive Analytical Assay

Favorite
W1230-05-039 - A Physiologically Based Pharmacokinetic Model of Rivaroxaban: Role of OAT3 and P-gp Transporters in Renal Clearance

Favorite
M1430-05-035 - A Preclinical Population Pharmacokinetic Model for INBRX-101, a Recombinant Human AAT-Fc Fusion Protein

Favorite
W1230-05-035 - A Preliminary Quantitative System Pharmacology Model of Chimeric Antigen Receptor T cell Therapy in Cancer Patients

Favorite
T1030-05-040 - A Retrospective Investigation of Post-Complete Response Letter (CRL) Meeting Requests (MRs) Related to Bioequivalence Assessment in Abbreviated New Drug Applications (ANDAs)

Favorite
T1130-05-036 - A Semi-Physiological Modeling and Simulation Approach for Guided Decision Making in R&D

Favorite
M0930-05-035 - Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review

Favorite
W0930-05-033 - An Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone following a Single-Dose Administration of Abiraterone Acetate 250 mg Tablets to Healthy Subjects

Favorite
T0930-05-033 - An Evaluation of the Pharmacokinetics of Tiotropium following a Single-Dose Inhalation in Healthy Subjects Using an Ultrasensitive Bioanalytical Method

Favorite
M1430-05-040 - AR-42 Pharmacokinetics: Estimated versus Measured Patient Body Composition

Favorite
T1530-05-033 - Assessing the Role of Intracellular Binding Protein in Drug-Induced Bile Acid Transporter Inhibition Using Quantiative Systems Pharmacology (QSP) Modeling

Favorite
T1030-05-036 - Assessment of Bioavailability of Diclofenac from Two Topical Drug Products using Pharmacokinetic and Skin (Tape) Stripping Analyses

Favorite
T1030-05-033 - Assessment of Factors Affecting Intrasubject Variability of Drugs Evaluated for Bioequivalence

Favorite
M1030-05-033 - Assessment of Local and Systemic Bioavailability of Lidocaine from Two Lidocaine Topical Delivery Systems using Pharmacokinetic and Skin (Tape) Stripping Analyses

Favorite
T1530-05-034 - Assessment of Pharmacokinetic (PK) Comparability Studies on Prefilled Syringes (PFS) and Autoinjectors(AI) for Biological Products

Favorite
M1230-05-033 - Automated Average Bioequivalence Analysis with Additional Metrics and Statistics to Meet the FDA guidance on Methylphenidate Hydrochloride Using Phoenix® WinNonlin®.

Favorite
M1030-05-038 - Awareness, Attitude, and Knowledge toward Oral Contraceptive Use Among Korean Women

Favorite
T0930-05-035 - Capturing, Counting and Identifying CECs: A Potential Diagnostic Marker for Patients with Pulmonary Arterial Hypertension

Favorite
M0930-05-037 - Characteristics of the Luminal Environment in the Lower Intestine of the Elderly which are Relevant to Drug Absorption and Comparison with the Adult Population

Favorite
M1530-05-035 - Characterization of Plasma Membrane Localization and Phosphorylation Status of Organic Anion Transporting Polypeptide (OATP) 1B1 c.521 T>C Polymorphism

Favorite
T1430-05-035 - Clinical Pharmacokinetic Study of Olmesartan/Amlodipine/Rosuvastatin Fixed-Dose Combination Tablet

Favorite
W1130-05-038 - Common Bioequivalence Deficiencies in Abbreviated New Drug Applications (ANDA) of Transdermal Delivery System (TDS) Products

Favorite
T1430-05-037 - Comparison of the Pharmacokinetics of Four Different Dose-Frequency Combinations of AMZ001 (Diclofenac Gel 3.06%) with Voltaren® (Diclofenac Gel 1%) in Healthy Subjects in a Phase 1 Study

Favorite
W0930-05-034 - Could SNPs Predict Cisplatin Toxicity?

Favorite
M1030-05-034 - Could Toxicities and Oxidative Stress Due to Cisplatin be Ameliorated with the Use of Acetylcysteine without Decreased Antitumor Efficacy? A Randomized Double-Blind Placebo-Controlled Trial

Favorite
M1530-05-039 - Developing a 3-D Cell Culture Model of Chemically Induced Oral Mucositis

Favorite
T0930-05-036 - Development and Evaluation of a New Aspirin Formulation

Favorite
M1230-05-035 - Development and Validation of a PBPK Model to Predict Plasma and Sputum Exposures after IV, Oral or Inhalation Administration of Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients

Favorite
M1230-05-037 - Development and Verification of Population Level IVIVC Using Mechanistic PBPK Modeling for Trazodone Extended Release Formulations to Support Biowaiver for SUPAC Changes to the Formulation

Favorite
W1030-05-034 - Development of a Microfluidic Cell Culture Platform for High Throughput Quantitative Drug Screening

Favorite
M1430-05-033 - Development of a Population Pharmacokinetic Model to Characterize Cocaine and Metabolites Behavior in Mice

Favorite
W1230-05-038 - Development of an Ocular Physiologically-Based Pharmacokinetic Model to Describe the Impact of Formulation Attributes on the Disposition of an Antibiotic Applied on the Rabbit Eye

Favorite
T1130-05-035 - Development of In Vitro In Vivo Correlation Model for Testosterone Transdermal Gel Product

Favorite
W1030-05-037 - Development of the Lipid Nanoparticles Loaded with Immunostimulatory Oligodeoxynucleotide for Cancer Therapy

Favorite
W1130-05-034 - Disease Progression Modeling of Placebo-response in Analgesic Clinical Trials

Favorite
M1530-05-037 - Do Uremic Solutes Potentially Affect UDP-Glucuronosyltransferase (UGT) Enzymes?

Favorite
M1130-05-037 - Droplet Evaporation from a Solution-Based Metered Dose Inhaler: A Computational Approach

Favorite
W1230-05-033 - Drug-Induced TMDD: A Novel Class of PK Models for Immune-Stimulating Therapies

Favorite
M1530-05-034 - Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Kinetics and Inhibition of Bile Acid Transport by Cholestatic Medications

Favorite
T1430-05-036 - Effect of Adhesion on Pharmacokinetics (PK) of Transdermal (TDS) Topical Products

Favorite
M1130-05-036 - Effect of Counseling on Cost Effectiveness Analysis in Diabetes Mellitus Patients

Favorite
W0930-05-036 - Effect of CYP2D6 Genetic Polymorphism on the Pharmacokinetics of Zolpidem

Favorite
M0930-05-033 - Evaluation of Dermal Open Flow Microperfusion (dOFM) as a General Methodology to Assess the Bioequivalence of Hydrophobic, Protein-Bound Topical Drug Products

Favorite
W1130-05-036 - Evaluation of Pain from Microneedle Use in the Oral Cavity of Human Volunteers

Favorite
W1030-05-033 - Evaluation of Reapplication and Controlled Heat Exposure on Oxybenzone Permeation from Commercial Sunscreen Using Excised Human Abdominal Skin

Favorite
T1330-05-035 - Exosomes as Delivery Vehicles for Biomolecules

Favorite
W1230-05-036 - Extended Physiologically-Based Pharmacokinetics (PBPK) Modeling Approach for Effects of Obesity

Favorite
T1130-05-034 - Extracellular Matrix Softening Promotes SH-SY5Y Neuroblastoma Softening and Actin Depolymerization to Selectively Increase Abeta(1-42) Endocytosis

Favorite
T1530-05-038 - Formation of Primaquine-5,6-orthoquinone, the Putative Active and Toxic Metabolite of Primaquine via Direct Oxidation in Human Erythrocytes

Favorite
T1130-05-033 - GAA-iTEM, an In Silico Personalized Prediction Tool to Identify Infantile Pompe Disease (IPD) Patients at High Risk of Developing Anti-drug Antibodies (ADA)

Favorite
M1430-05-037 - Gastrointestinal Transit Kinetics of Cefaclor and Cefadroxil in Cystic Fibrosis (CF) Patients and Healthy Volunteers Compared via Population Pharmacokinetics

Favorite
M1330-05-037 - General Pharmacokinetic Features of Small Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD)–A Simulation-Based Study

Favorite
T0930-05-037 - Generic Transdermal Drug Delivery System (TDDS): Region-Specific Requirements

Favorite
T1030-05-039 - Histological Evaluation of Obstructed Insulin Pump Catheters Explanted from Patients

Favorite
M1330-05-036 - HTPK: Conducting PK Modeling and Simulations at High Speed

Favorite
T1130-05-038 - Importance of Physiologically Based Pharmacokinetic (PBPK) Modeling Approaches for Development of Dissolution Method; To Learn from Clinical Non-bioequivalent (BE) Data

Favorite
M1530-05-038 - In Vitro Evaluation of Metabolism-Based Drug Interactions with Sunscreen Ingredients

Favorite
W1230-05-037 - In Vitro to In Vivo Extrapolation (IVIVE) of Itraconazole Precipitation using a Biphasic Dissolution Test and Mechanistic Absorption Model

Favorite
M1130-05-033 - In Vivo Pharmacokinetics of Levofloxacin Niosomes

Favorite
M1330-05-033 - Inferring Target Occupancy from Fitting Nonlinear-PK Data with Mechanistic PKRO Model for Pembrolizumab

Favorite
W1030-05-039 - LC-MS/MS Method Validation of Loperamide Hydrochloride for an In Vitro Transporter Assay

Favorite
T1530-05-036 - Liver Safety Comparison of Two Treatments for Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Using Quantitative Systems Toxicology Software (DILIsym)

Favorite
T1230-05-036 - Mechanistic Prediction of Effect of P-glycoprotein Inhibition on Oral Absorption and Disposition of Vemurafenib into the Brain Using IVIVE-PBPK

Favorite
M1330-05-035 - Modeling of the Antihypertensive Effect of Irbesartan and Hydrochlorothiazide Combination

Favorite
M1230-05-036 - Multi-Phase Multi-Layer Mechanistic Physiologically Based Pharmacokinetic Dermal Absorption Model Verification including Inter and Intra Individual Variability Assessment Using Nicotine as Model Drug

Favorite
W1030-05-035 - Neuroprotection by Activation of a TrpV1 Receptor Using Resiniferatoxin, against 6-OHDA Induced Toxicity and Revealing TrpV1 Mediated Pathway for Neurotrophic Activity in Neurodegenerative Disorders

Favorite
T1530-05-039 - P-Glycoprotein Drug Interaction Risk Assessment Based on In Vitro Data; Comparison of a Vesicle- Versus a Cell-Based Assay

Favorite
M1130-05-035 - Pharmacokinetic Modeling of the Effect of Recombinant Human Hyaluronidase (rHuPH20) in Subcutaneous Absorption

Favorite
W0930-05-035 - Pharmacokinetics Interaction between Metformin Hydrochloride 1500 mg and Rosuvastatin 20 mg in Healthy Subjects

Favorite
T1330-05-036 - Pharmacokinetics, Safety and Efficacy of Solid Lipid Boswellia serrata Particles (SLBSP) For Symptomatic Treatment of Osteoarthritis of Knee.

Favorite
T1030-05-035 - Pharmacokinetics/Pharmacodynamic Studies of Metformin in a Phase I Dose-Escalation Study in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients

Favorite
M1530-05-033 - Photochemical Internalization to Improve the Therapeutic Indices of Chemotherapy Drugs

Favorite
T1230-05-038 - Physiologically Based Pharmacokinetic Modeling of Carvedilol in CYP2D6 Genetic Polymorphism

Favorite
T1130-05-039 - Physiologically Based Pharmacokinetic Modeling of Tamsulosin in relation to CYP2D6 genetic polymorphism

Favorite
T1030-05-034 - Plasmatic and Urinary Biomarkers of Oxidative Stress and Toxicities Induced by Cisplatin in Head and Neck Cancer Patients

Favorite
W1230-05-034 - Population Pharmacokinetic-Pharmacogenetic study of atazanavir/ritonavir in Thai HIV-infected patients

Favorite
M1430-05-034 - Population Pharmacokinetics of Durvalumab Following Combination Therapy with Olaparib in SCLC, Ovarian, Breast and Gastric Cancer Patients

Favorite
M1430-05-036 - Population Pharmacokinetics of Rituximab in Membranous Nephropathy

Favorite
M1430-05-038 - Population Pharmacokinetics of Subcutaneously- and Intradermally- Administered Glucagon in Type 1 Diabetic Patients

Favorite
W1130-05-037 - Preclinical activity and pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD+ AML

Favorite
T1030-05-038 - Pre-Clinical and Clinical Assessment of Letrozole Steady-State Pharmacokinetics in Malignant Gliomas: Application of Physiologically-Based PK Modeling to gain Quantitative and Mechanistic Insights

Favorite
T1230-05-037 - Predicting Depth Resolved Concentrations in the Dermis using PBPK modelling: Design, development and verification of the model with five drugs

Favorite
W1030-05-038 - Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 3

Favorite
M1130-05-034 - Reference-Scaled Average Bio-Equivalence (SABE): A Promising Statistical Approach to Analyze Cutaneous Pharmacokinetic Results for Topically Applied Drug Products

Favorite
W1030-05-036 - Regulation of Human Organic Anion Transporters 3 by Protein Kinases A: Crosstalk between Sumoylation and Ubiqitination

Favorite
T1030-05-037 - Relative Bioavailability, Effect of Food, Gender Difference, Safety, and Tolerability of Etrasimod, a Next-Generation, Oral, Selective Sphingosine 1-Phosphate Receptor Modulator, in Healthy Subjects

Favorite
T1330-05-037 - Review of Substrates and Inhibitors Used in Transporter-Mediated Clinical Drug-Drug Interaction Studies

Favorite
M0930-05-036 - Safety, Pharmacokinetics and Pharmacodynamics of CNTO 7160, an Anti-IL-33R Monoclonal Antibody, in a First-in-Human Study in Healthy Subjects, Subjects with Asthma, and Subjects with Atopic Dermatitis

Favorite
T1230-05-034 - Tackling Ineffective Metformin Dosing in Type 2 Diabetic Children Using a Physiologically-Based Pharmacokinetic Model and Individualized Dosing

Favorite
T0930-05-034 - The effects of Warfarin long use in quality of life and treatment adherence in patients with Primary Antiphospholipid Syndrome.

Favorite
T1430-05-033 - The efficacy and safety effects of Cordyceps militaris extract supplement (D.C. Daily®) in vivo models and clinical trial

Favorite
M1530-05-036 - Transplacental Transfer of Doxorubicin and Doxil® (PEGylated Liposomal Doxorubicin) across BeWo b30 Trophoblast Cell Monolayers

Favorite
T1130-05-037 - Understanding the Impact of Age-Related Changes in Paediatric Gastrointestinal Solubility by Multivariate Data Analysis

Favorite
M1230-05-038 - Updated Physiologically Based Pharmacokinetic (PBPK) Model for Acetaminophen Metabolism with an Emphasis on Phase I Metabolism

Favorite
M1230-05-034 - Use of Electronic Medical Records and a DNA Biobank to Develop a Population Pharmacokinetic Model for Tacrolimus

Favorite
T1530-05-035 - Using Visualization to Address the Reliability of Sources of Initial Parameter Values in a Quantitative Systems Pharmacology Model

Favorite
Formulation and Quality
T1230-12-092 - 4D Printing for Fabrication of Retentive Intravesical Drug Delivery Systems Based on Poly(vinyl alcohol)

Favorite
T1330-11-088 - A 14 Day Gastric Resident Oral Formulation of Ivermectin for Prevention of Malaria Transmission

Favorite
M1230-09-069 - A 3D Bioprinted In Situ Conjugated-co-Fabricated Scaffold for Bone Tissue Engineering Applications

Favorite
T1030-09-065 - A Comparative Study of Two Liposomal Delivery Systems Targeted for Glioblastoma Multiforme

Favorite
W0930-12-095 - A Comparison of Formulation Approaches for a Small Molecule with a Short Biological Half-Life for the Treatment of Irritable Bowel Syndrome (IRB)

Favorite
T1330-08-063 - A Dual Delivery System for Antibiotics and Probiotics: An In Vitro, Ex Vivo, In Vivo and In Silico Evaluation

Favorite
M1030-07-049 - A Flow-Through Dissolution Method for Evaluation of Drug Release from Manipulated Abuse Deterrent Formulations

Favorite
T1230-12-091 - A Formulation-by-Design Approach to Design and Fabricate FDM 3D-Printed Tablets with Pre-defined Release Kinetics

Favorite
M1330-07-055 - A General Practical Approach for Trace Level Determination of Arylamine Genotoxic Impurities in Drug Substances

Favorite
M1130-09-070 - A Low Volume Microfluidic Multiplexed Viscometer for Newtonian and Non-Newtonian Fluids

Favorite
M1430-13-099 - A Material-Sparing Approach for Developing Sildenafil Orally Disintegrating Tablet

Favorite
T1030-10-073 - A Mathematical Model Linking the Formation of Amorphous Solid Dispersions with Hot-Melt-Extrusion Process Parameters

Favorite
M1230-07-050 - A Mathematical Model to Determine Actual Drug Release Kinetics from Nanocarriers using Dialysis Methods

Favorite
T0930-12-093 - A Microfluidic Platform for Rapid Production of Scalable, Tunable, and Controlled Lipid Nanoparticles

Favorite
M1230-09-072 - A Modified USP Induction Port To Characterize Nasal Spray Plume Geometry And Predict Turbinate Deposition Under Flow

Favorite
T1430-10-080 - A New Excipient for Effective Taste Masking at Low Coating Levels

Favorite
W1130-13-103 - A Novel Approach for the Fabrication of Nanoparticle Agglomerates for Pulmonary Drug Delivery

Favorite
T1530-07-050 - A Novel Approach to Keloid and Hypertrophic Scar Therapy: Sustained Release of Proteases from PLGA Microspheres.

Favorite
M1030-10-074 - A Novel Architecture to Enable High Active Loading of Tablets of Amorphous Spray Dried Dispersions

Favorite
W1130-08-063 - A Novel Cyclodextrin-Based Pickering Emulsions for Prolonging the Duration of Topical Local Anesthesia

Favorite
T0930-10-079 - A Novel Solid Self-nanoemulsifying Drug Delivery System (S-SNEDDS) for Improved Stability and Oral Bioavailability of an Oily Drug, 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol

Favorite
T1430-07-049 - A Novel S-sulfhydrated Human Serum Albumin Preparation Suppresses Melanin Synthesis

Favorite
W1130-11-085 - A Patient-Centric Approach: Formulation of Prolonged Release Microparticles to be Used in Oral Suspensions for Older Patients with Dysphagia

Favorite
T1130-13-104 - A PBPK Model of the Negative Effect of Chitosan on Acyclovir Absorption: The Mucus-Chitosan Interaction

Favorite
M1430-11-083 - A Platform Formulation Approach for Rapid Development of Controlled Release Multiparticulates for Early Clinical Studies

Favorite
T1130-08-062 - A Promising Lyophilized Orodispersible Tablets of Ethyl Morphine Hydrochloride for Clinical Use

Favorite
M1330-07-056 - A Quality by Design Approach to Analytical HPLC Method Optimization

Favorite
T1330-12-090 - A Review of Recent Progress in GDUFA Research Program on PLGA-Based Drug Products: Three Case Studies

Favorite
M1030-10-079 - A Simple Rheological Method for Polymer Selection in Amorphous Drug Solid Dispersions

Favorite
T1130-07-051 - A Simple, Accurate and Economical Method for Quantitative Estimation of Calcium Acetate Capsules by High Performance Liquid Chromatography Using UV Detector

Favorite
W0930-09-067 - A Smart Macrophage Bioreactor for Deep Penetrating Delivery of Anti-Tumor Peptide for Breast Cancer Therapy

Favorite
T1030-11-086 - A Spectroscopic Assessment of Interaction Anisotropy in Pharmaceutical Materials: Assessing Potential Drug Candidates for Direct Compression

Favorite
M1330-11-081 - A Study of the Impact of Excipient Shielding on Initial Drug Release Using UV Imaging

Favorite
M0930-09-071 - A Systematic Approach to Formulate and Evaluate the Stability of Topical Creams with High Concentrations of Transcutol® HP

Favorite
M0930-09-070 - A Transdermal Electro-Modulated Hydrogel- Microneedle Device for Chronic Pain

Favorite
T1230-07-050 - A Validated 19F NMR Technique to Assay Quantitatively Fluorinated Synthetic Cannabinoid Agonists

Favorite
T1030-13-099 - Absorptive Dissolution Testing of Supersaturating Systems: Impact of Absorptive Sink Conditions on Solution Phase Behavior and Mass Transport

Favorite
M1230-09-070 - Abuse Deterrent Immediate Release Egg-Shaped Tablet Using 3D Printing Technology: Multifactorial Design to Optimize Release and Extraction

Favorite
M1530-11-081 - Abuse-Deterrent/Crush-Resistant (ADCR) System: A Novel In Situ Sintering Matrix

Favorite
T1430-10-075 - Acoustic Detection of Capping Risk in Solid Dosage Forms

Favorite
W0930-08-060 - Activity and Delivery of Novel mitoNEET Ligand NL-1 for Cerebral Ischemia Reperfusion Injury

Favorite
W0930-10-077 - Adsorbing the Poorly Water Soluble Drug on Porous Calcium Silicate by Sealed Heating Method

Favorite
T1530-10-077 - Advantage of Various Pellet Coating Techniques Using Hypromellose Acetate Succinate (HPMCAS)

Favorite
W1230-11-082 - Advantages of Spongy PLGA Microsphere as Parenteral Depot Injection

Favorite
T1230-10-073 - Altering Particle Size and Shape during the Precipitation of API in Aqueous Solvent Systems

Favorite
M1430-10-080 - Amorphous-Based and Crystalline-Based Solid Dispersion-An Industrial Assessment

Favorite
M0930-13-103 - An In Vitro Biorelevant Assessment of Prussian Blue

Favorite
M1130-13-101 - An Integrated Experimental and Modelling Approach to Characterize the Precipitation Kinetics of Compounds with Poor Aqueous Solubility: From In Vitro to In Vivo Predictions

Favorite
T1530-09-068 - An Investigation into the Thermal Stability of a Cocrystal Form of Hydrochlorothiazide/Nicotinamide: Thermally Induced Coamorphous Drug Forms

Favorite
T1530-07-049 - An Isolated Perfused Rat Lung Model for Studying Controlled and Targeted Release of Fasudil, an Anti-PAH Drug from Peptide Grafted Liposomal Formulations

Favorite
T1230-09-067 - Analgesic Effect of Diclofenac Sodium Loaded Dissolving Microneedle Patches in Treatment of Glacial Acetic Acid Induced Acute Inflammation in Rats

Favorite
T1530-08-062 - Antibacterial Agent Loaded Nano-lipid Carriers for the Selective Mitigation of Pathogenic Bacteria and Their Biofilms in the Skin

Favorite
M1130-08-057 - Anticancer Effects of Tannic Acid on Non-small Cell Lung Cancer

Favorite
T1030-08-060 - Antinociceptive Effects of a Multifunctional Burn Wound Dressing in Rat Model of Second Degree Burn Injury

Favorite
M1430-10-073 - API and Precipitation Inhibitor Co-Loaded Mesoporous Silica: A Novel Synergistic Formulation Type with Advantageous Dissolution Performance

Favorite
T0930-11-081 - Apparent Molal Volumes of a Non-ionic Surfactant Derived from Castor Oil in Microemulsions with Various Polar Oils

Favorite
T1230-07-053 - Application of 19F Solid-State NMR Spectroscopy for Detection of Low Levels of Crystalline Content in Amorphous Solid Dosage Forms

Favorite
M1430-07-055 - Application of 2D NMR for Structural Characterization of Monoclonal Antibodies

Favorite
W1030-09-070 - Application of 3D Printing Technology and Quality by Design Approach for the Development of Age Appropriate Formulation

Favorite
T1330-11-081 - Application of Cellulosic Polymers in Delayed Release Coating of Diclofenac Sodium Tablets

Favorite
W0930-07-055 - Application of DOSY NMR to Droplet Size Measurement for Emulsion Drug Products

Favorite
M1530-07-055 - Application of NIR to Monitor the Secondary Drying of a Spray Dried Intermediate

Favorite
W1030-13-103 - Application of QbD Principles to Late Phase Clinical Development

Favorite
W1230-11-084 - Application of Thermo-Sensitive Hydrogel for Changing the PK of PPS1D1-M to Avoid Acute Toxicity

Favorite
M1130-13-102 - Applying Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation for Quality Risk Assessment: The Impact of Drug Substance Particle Size of BCS Class II Drug on the In Vivo Performance

Favorite
T1530-10-079 - Are Excipients Inert? Phenytoin: A Follow-up Half a Century Later with New Incompatibility Insights

Favorite
T1230-07-051 - Artificial Gut Simulator for Simultaneous Evaluation of Dissolution and Absorption of Supersaturating Drug Formulations

Favorite
T1130-11-088 - Asparagine Deamidation in the Fc Region of Therapeutic Monoclonal Antibody–Effect of Selected Mutations on Fc-Receptor Binding and Deamidation

Favorite
T1530-08-064 - Assessment of Bioavailability of Rivastigmine from Two Rivastigmine Transdermal Delivery Systems with and without Exposure to Heat Using In Vitro Permeation Test (IVPT)

Favorite
M1130-12-089 - Assessment of Compressibility and Compactibility of Pharmaceutical Powders and Their Binary Mixtures Using Percolation Theory

Favorite
M1230-11-081 - Assessment of Drug Gastrointestinal Supersaturation Using In Vitro Dissolution Absorption System 2 (IDAS2)

Favorite
T1130-07-054 - Assessment of Drug Quality Using the Regulatory Framework of the FDA-DOD Shelf-Life Extension Program to Extend the Expiration of Medical Drug Products

Favorite
M1430-12-092 - Assessment of Quality Control Parameters and In Vitro Bioequivalence/Interchangeability of Multisourced Marketed Metformin Hydrochloride Tablets in the State of Qatar

Favorite
M1530-08-063 - Assessment of Radiation Sterilization Impact on Rheological Properties and In Vitro Release Profiles of a Thermo Responsive Topical Gel

Favorite
T0930-11-084 - Assessment of the pH-Stability Profile of Epinephrine for Sublingual Administration

Favorite
W0930-10-073 - Autoclave Vial Delamination Revisited: SWFI vs. Captisol® Solutions

Favorite
W0930-07-052 - Automated Particle Count Analysis for Protein Formulation Optimization to Minimize Aggregation and Perform USP 787 Subvisible Particulate Matter Testing

Favorite
W0930-12-093 - Batch Age Effect on Potency and Pharmaceutical Quality of Brand Levothyroxine Sodium Tablets

Favorite
W0930-12-091 - Berberine Nanoparticles with Anti-Alzheimer Potential: Effect of Coating on Cerebrovascular Amyloid Targeting and Nanotoxicity in Rats

Favorite
M1030-09-068 - BergaCare SmartLipids® - Development of Commercial Concentrates of Phenylethyl Resorcinol for Skin Whitening

Favorite
W1130-07-050 - Bile Based Vesicles for Hepatocytes Specific Oral Delivery of Direct Acting Antiviral (DAA): Assessment of the Targeting Ability of the Charged and β-sitosterol Decorated Vesicles

Favorite
M1330-08-059 - Bioadhesive Nanocarrier Improve Cytotoxicity of Piplartine and Mammary Tissue Targeting by Intraductal Administration: A New Strategy for Treatment of In Situ Ductal Carconoma

Favorite
M1230-12-092 - Biodegradable Polymeric Micelles for Delivery of Irinotecan

Favorite
M1030-08-061 - Biodistribution Study of Intranasally Delivered liposomes

Favorite
T1330-08-060 - Bioengineering of Thermoreversible Hydrogels Loaded with Bone Morphogenic Protein-2

Favorite
M1430-09-067 - Biomimetic Formulation of Clofazimine Hydrochloride Microcrystals for Local Administration

Favorite
M0930-12-092 - Biomimetic Nanostructured Lipid Carrier Containing Paclitaxel Coated with Platelet Membrane

Favorite
T1430-07-051 - Bioreducible Cross-Linked Polypeptide Micelles for Enhanced Cancer Combination Therapy

Favorite
T1530-13-100 - BiPhasic Dissolution Tests Conducted at Low Buffer Capacity Conditions

Favorite
T1230-11-084 - Box-Behnken Design for the Optimization of Sustained-Release Tablet Formulation for Bupropion Hydrochloride

Favorite
T0930-08-064 - Brain Targeting of Ginsenosides Self-nanoemulsifying Drug Delivery System to Ameliorate Metabolic Syndromes and Keep Homeostatic Balance

Favorite
T1530-07-054 - Breast Cancer Chemoprevention: A New Liquid-Crystalline System for Sustained Local Drug Release

Favorite
M1130-10-073 - Built-In Quality of Cocrystal between Indomethacin and Saccharin at High Shear Granulation Process

Favorite
M0930-07-055 - Can One-Stage In Vitro Dissolution Using Water as Medium Represent Guaifenesin Release from Extended-Release Bilayer Tablets?

Favorite
M1330-10-075 - Can the Commonly used pH-Stat Titration Method be Improved Upon for Correlating Drug Release with Lipid-Based Formulation Digestion?

Favorite
T1130-07-049 - Category 1 Assessment: Vaping of Abuse Deterrent Opioid Formulations

Favorite
T1130-08-061 - Cell-Penetrating Peptide Enhances Efficacy of Paclitaxel Nanomicelles in Traditional 2D Monolayer Culture and Multicellular Tumor 3D Spheroids of Triple Negative Breast Cancer Cells

Favorite
M1130-09-072 - Challenges Encountered in Evaluating the Compatibility of Broadly Neutralizing Antibodies with Intravenous (IV) Fluids

Favorite
T1030-07-052 - Characterization and Quantification of Five Synthetic Cannabinoid Agonists (SCA) Using NMR and UHPLC-QTOF/MS/MS

Favorite
T1130-10-074 - Characterization of API Bulk Properties to Identify Quality Attributes to Support Formulation of Drug Product

Favorite
M1330-08-060 - Characterization of Drug-Loaded Milled Extrudate Particles Produced by Hot Melt Extrusion Technology for Dry Powder Inhalers

Favorite
W0930-08-061 - Characterization of GLUT-1 Targeted Nanoparticles for Drug Delivery to Brain for Treatment of Alzheimer’s Disease

Favorite
M1130-11-081 - Characterization of Lyophilized Cake Appearance and Compressive Strength

Favorite
W1230-10-076 - Characterization of SeaGel® Films for Soft-shell Capsule Applications

Favorite
M0930-09-065 - Characterization, Formulation and Topical Delivery of Terbinafine

Favorite
M1530-09-067 - Characterizing the Nature and Strength of Drug-Polymer Complexes in Aqueous Solution Using Analytical Ultracentrifugation

Favorite
T1230-13-097 - Clay-Polymer Nanocomposites Prepared by Reactive Melt Extrusion for Sustained Drug Release

Favorite
M0930-08-059 - Coated PLGA-Bevacizumab Implants for Long-Acting Anti-VEGF Efficacy in a Rabbit Retinal Vascular Leakage Model

Favorite
M1530-09-065 - Cocrystal Dissolution into Constant pH Media: Model Analysis

Favorite
T1430-09-072 - Cocrystal Superior Dissolution Performance and the Role of Supersaturation Index in Biorelevant Media

Favorite
W0930-11-083 - Co-extruded Fixed Dose Combination Products with Enabled Properties for the Treatment of Cardiovascular Diseases

Favorite
T0930-13-098 - Cold Flow Properties of Tulobuterol Patches

Favorite
T1230-11-083 - Colon Targeted Multiple Unit Pulsatile Drug Delivery of Ketoprofen - Eudragit® FS100 Pellets Prepared via Hot Melt Extrusion Technology

Favorite
T1130-11-084 - Colon-Targeted Lipase Releasing Microparticles for the Prevention of Diarrhea and Steatorrhea

Favorite
T0930-13-100 - Common Deficiencies in the Validation of Regulatory Analytical Procedures for ANDA Supplemental Applications

Favorite
T0930-11-087 - Compaction Performance and Mechanical Properties of Caffeine Cocrystals: A Polymorphic Study

Favorite
M0930-13-100 - Comparative Assessment of the Physical and Structural Similarity of Topical Drug Products containing Lidocaine and Prilocaine

Favorite
M1430-12-094 - Comparative Characteristics of Ovarian Cancer-Derived Bionanocarriers and Traditional Exosomes

Favorite
W0930-13-102 - Comparative Efficiency of GC/MS and LC/MS for Determination of Non-volatile Acidic Leachables

Favorite
W0930-09-066 - Comparative Permeation Study of a Novel Buprenorphine Transmucosal Dosage Form versus Sublingual Tablet and Buccal Film

Favorite
M1530-07-054 - Comparative Physicochemical Characterization between Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection

Favorite
W1130-09-072 - Comparative Stability of Oral Vitamin K Solutions Stored in Refrigerated Amber Plastic Syringes

Favorite
T1230-09-066 - Comparative Studies on Amphotericin B Nanosuspensions Prepared by High Pressure Homogenization Method and Anti-Solvent Precipitation Method

Favorite
T1230-08-058 - Comparison of Bilayer Hydroxyethylmethacrylate-Hyaluronate and Composite HPMC-Hyaluronate Films as Potential Ocular Drug Delivery Systems for Potential Treatment of Glaucoma

Favorite
T1030-13-102 - Comparison of Cataflam® Performance in the Dynamic Gastric Model (DGM) with a Human Aspiration Study

Favorite
M1030-07-055 - Comparison of Dissolution Behaviour of Aerosols from Pressurized Metered Dose Inhalers When Delivered by Next Generation Impactor and PreciseInhale®

Favorite
T1230-12-094 - Comparison of Hildebrand and Hansen Solubility Approaches in the Construction of Drug-Excipient Thermodynamic Phase Diagrams Using Flory-Huggins Solution Theory

Favorite
W1230-13-097 - Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations

Favorite
T1030-13-104 - Comparison of Solubility and Dissolution Behavior of Ibuprofen or Ketoconazole in Fed State Simulated Intestinal Fluid (FeSSIF, Made from Commercial Powder or from Scratch) or USP Buffer

Favorite
W1130-10-076 - Comparison of the Results Generated and Methods Employed by Shear Cells of Varying Sizes and Geometries with Common Excipients and Active Pharmaceutical Ingredients

Favorite
M1330-09-071 - Comparison of the Surface Energetics of Various Co-crystal Systems with Their Physicochemical Properties

Favorite
W1130-10-075 - Complexity of Setting Compendial Specifications for Excipient Composition and Impurities

Favorite
T0930-07-050 - Comprehensive Analysis of Polysorbate 80 Degradation Using Mass Spectrometry and Automated Polysorbate Species Identification

Favorite
M1230-09-065 - Computer-Aided Geometric Design of Outlet Channel in the Mouthpiece of DPI Device

Favorite
M1030-11-086 - Conformational Structure and Physical Stability of Teriparatide: Implication on Product Quality

Favorite
T1430-09-065 - Congruent Release of Drug and Polymer: A Sweet Spot in the Dissolution of Amorphous Solid Dispersions

Favorite
T1130-07-052 - Construction of Drug-Lipid Thermodynamic Phase Diagrams by Analysis of Melting Point Depression through Application of Flory-Huggins Interaction Theory

Favorite
T1430-12-093 - Continuous Preparation of Self-assembled Clofazimine-Loaded Particles by Flash Nano-Precipitation (FNP)

Favorite
W1230-12-091 - Contribution of Crystal Lattice Energy on the Dissolution Behavior of Eutectic Solid Dispersion

Favorite
M1330-13-102 - Contribution of Surface Modification in Cellular Uptake, Endosomal Escape and Transfection Efficiency of Dual-Functionalized Liposomes Loading Plasmid DNA

Favorite
W1030-07-054 - Controlled Release Mini-tablets: An Innovative Approach to Improving Pediatric and Geriatric Patient Compliance

Favorite
W1030-07-056 - Controlled Release of Doxorubicin Using Fe-Based Nano Biocomposite Impregnated in Bio Polymeric Matrix

Favorite
M1230-09-071 - Correlation between Drug-Lipid Interaction and Phase Solubility for Preformulation of Hydrophilic Drug Loaded Solid Lipid Nanoparticles

Favorite
W1230-12-090 - Correlation between Skin Irritation Potentials of Cosmetic Raw Materials Evaluated by Different Skin Irritation Testing Methods Using Reconstructed Human Skin Tissues and Human Skin Cells

Favorite
M1230-08-061 - Corticosteroid-Loaded Biodegradable Nanoparticles for Treating Experimental Autoimmune Uveitis

Favorite
M0930-09-072 - Co-Spray Dried Inhalable Netilmicin/L-leucine Dry Powder with Hygroscopicity Reduction to Improve Aerosolization Performance for Respiratory Infections Treatment

Favorite
M1430-11-082 - Critical Steps Design and Optimization in Modified Release Pellets by Extrusion–Spheronization Technique

Favorite
T1430-09-067 - Crystal Engineering of Novel Pharmaceutical Cocrystal of Itraconazole with Suberic Acid

Favorite
M1230-10-076 - Crystallinity Risk Assessment in the Performance of Amorphous Solid Dispersions

Favorite
W1230-12-092 - CytoVessel – A Novel Hermetic Dissolution System for Hazardous Drugs

Favorite
T1130-12-093 - Decreasing Pharmaceutical Powder Cohesiveness with Mesoporous Silica Particles

Favorite
M1530-10-077 - Degradation Kinetics Study of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) by a Validated Stability-Indicating RP-HPLC Method

Favorite
T1030-09-066 - Delayed Release Coating Formulations Targeting Lower GI Tract

Favorite
W1130-08-061 - Demonstration of Sweat Resistant Transdermal Drug Delivery System

Favorite
M0930-09-067 - Dermal Patch for Extended Delivery of Pirfenidone to Deep Partial-Thickness Burns

Favorite
M1230-09-067 - Design and Characterization of Shear-Sensitive Fattigation-Platform Albumin Nanoparticles

Favorite
W1130-07-054 - Design and Evaluation of Esomeprazole Enteric Coated Micropellet Formulations

Favorite
M1530-08-057 - Design and Evaluation of Poly lactic-co-glycolic Acid Based In Situ Film Forming System for Topical Delivery of Trolamine Salicylate

Favorite
T1530-13-097 - Design of a New Disintegration Test System for Evaluation of Orally Disintegrating Films

Favorite
W1030-08-064 - Design of Ionic Liquid-Based Film-Forming Oral Spray Formulations of Vitamin B12

Favorite
W1030-09-069 - Design of Patient-Centered Sublingual Dosage Form Containing Low Dose Emergency Medicine with Content Uniformity and Taste Masking

Favorite
M1230-13-103 - Design, Development and Characterization of Cannabidiol Loaded Microspheres for Ovarian Cancer Therapy: In Vitro and In Ovo Evaluation

Favorite
W1030-07-052 - Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films

Favorite
W1230-08-058 - Design, Optimization and Preparation of Nanotechnological Approaches for Topical and Transdermal Pathways

Favorite
M1330-13-098 - Designing Biocompatible Polymer for Efficient Oral Gene Delivery

Favorite
W1230-12-093 - Detection of the Onset of Aggregation as a Function of pH of Iron Oxide Nanopowder by Dynamic Light Scattering

Favorite
T1030-10-077 - Determination of Drug Release Rates during an In Vitro Self-Emulsification Process Using Dynamic Pulsatile Microdialysis (Dynamic PMD)

Favorite
M1230-07-053 - Determination of Sodium Chloride in Yeast Extract by Ion Chromatography

Favorite
T1030-10-075 - Determination of the Effects of the Surfactant Sodium Lauryl Sulfate (SLS) on the Free Dissolved Concentrations of Ibuprofen, Benzocaine and Griseofulvin in Solution Using Pulsatile Microdialysis (PMD)

Favorite
W1030-11-087 - Determination of the Upper Limit of the Metastable Zone for Supersaturated Diazepam

Favorite
T1230-13-098 - Determining the Formulation, Processing and Release of a Sustained Release Softgel Capsule

Favorite
T1330-13-098 - Developing Cold Chain Independent Vaccines - Spray-drying of Virosomes to Produce Dry Powder Formulations

Favorite
T1030-11-085 - Developing Sustained Release Delivery Systems for Hydrogen Sulfide: Influence of Dissolved Oxygen in Releasing Media and its temperature

Favorite
W1230-13-101 - Development and Approval of a Palatable Glycopyrronium Bromide Liquid Formulation for Pediatrics

Favorite
T1530-08-057 - Development and Characterization of a Transdermal Patch for 3-fluoroamphetamine

Favorite
M0930-08-063 - Development and Characterization of an Antibiotic-Eluting Bone Void Filling (ABVF) Putty for Osteomyelitis Treatment

Favorite
W1030-08-060 - Development and Characterization of Aspirin Loaded Wafers for Buccal and Oral GIT Delivery for Patients with Dysphagia

Favorite
W1230-07-055 - Development and Characterization of Composition-Equivalent Formulations to the One-Month Lupron Depot®

Favorite
T1430-11-086 - Development and Characterization of Composition-Equivalent Formulations to the Sandostatin LAR® by the Solvent Evaporation Method

Favorite
W1230-07-052 - Development and Characterization of Controlled Release Pellets from Aqueous Ethyl Cellulose Dispersions containing Water Soluble/Hydrophilic Plasticizers as Pore-Formers

Favorite
T1430-09-069 - Development and Characterization of Flurbiprofen-Pyrazinamide Cocrystal Formulation as Potential Combination Therapy for Treating Tuberculosis

Favorite
M1230-10-079 - Development and Characterization of In Situ Self-Assembly Nanoparticles for Oral Docetaxel

Favorite
M1430-08-061 - Development and Characterization of Inhalable siRNA Loaded Nanoliposomes

Favorite
M1530-11-084 - Development and Characterization of Liposomes for Treatment of Asthma

Favorite
M0930-07-051 - Development and Characterization of Simulated Gastrointestinal Fluids Representing Patients with Ulcerative Colitis

Favorite
T1130-08-059 - Development and Evaluation of Bone-Targeting Nanoparticle (BTN) as a New Treatment of Bacterial Bone Infections

Favorite
T1330-08-064 - Development and Evaluation of Chemodrug-Loaded Albumin Polymeric Nanocarriers for the Treatment of Neuroblastoma

Favorite
T1430-11-081 - Development and Evaluation of Dry Enteric Coating Approach for Lansoprazole Delayed Release Pellets Using Hypromellose Acetate Succinate (HPMCAS)

Favorite
W1030-10-077 - Development and Optimization of Instanute Coating Formulation containing Calcium Carbonate as an Opacifier

Favorite
T1530-11-083 - Development and Physicochemical Characterization of Protein-Lipid Hybrid Nanoparticles as a Drug Carrier Platform

Favorite
W1030-09-067 - Development and Processing of Spider Silk as a Biopolymer for a Hemocompatible Catheter Coating

Favorite
T1030-07-053 - Development and Validation of a GC-Headspace Method for the Determination and Quantification of Residual Solvents in Transdermal Drug Delivery Systems (TDS)

Favorite
T1530-08-060 - Development and Validation of a HPLC Method for the Analysis of β-caryophyllene and Evaluation of its Potential as a Candidate for Transdermal Drug Delivery

Favorite
M1030-12-091 - Development and Validation of a Rapid GC-FID Method to Simultaneously Determine Triethylamine, Diisopropylamine, and 1,1,3,3-Tetramethylguanidine Residues in an API

Favorite
M1130-13-100 - Development and Validation of an In Vitro In Vivo Correlation (IVIVC) for Oxybutynin Chloride Extended Release Tablets

Favorite
W0930-07-049 - Development and Validation of an Ion Chromatography Method to Determine Zinc Oxide in Sunscreens

Favorite
T1330-09-070 - Development of 3D Printed Tablets by Fused Deposition Modeling for Rapid Drug Release

Favorite
M1130-11-088 - Development of a Generally Applicable Method to Determine the Encapsulation Efficiency of Proteins in Polymer Matrices

Favorite
T1330-07-052 - Development of a Modified Release Tablet Containing an API Prone to Form Changes and Gelling in Aqueous Media

Favorite
W1030-11-088 - Development of a Mucoadhesive Mouthwash: An Integrated Approach to Evaluate the Mucoadhesive Properties

Favorite
M1130-08-058 - Development of a New Nanoemusion System Intended for Targeted Drug Delivery to HIV Lymphocyte Reservoir

Favorite
T1130-12-094 - Development of a Novel Gastro-Floating System for Acyclovir by Using 3D Printing Technology.

Favorite
W0930-11-082 - Development of a Novel Oral Fast-Dissolving Film for Pediatric Use

Favorite
M1230-08-058 - Development of a Novel Sustained Release In Situ Gelling System for the Treatment of Uveal Melanoma

Favorite
M1330-07-054 - Development of a Reverse-Phase HPLC Method for a Pyruvic Acid Derivative in a Semisolid Dosage Form

Favorite
M1330-07-053 - Development of a Robust Qualitative Method Using Near-Infrared Spectroscopy and Support Vector Machine to Monitor Pharmaceutical Product Quality in the Low-Resource Setting

Favorite
T0930-13-103 - Development of a Scientific Framework for Extension of Medication Shelf-Lives beyond Declared Expiration Dates

Favorite
T1230-13-102 - Development of a Semifluorinated Nanoemulsion Platform for Tunable Therapeutic and Diagnostic Delivery

Favorite
W1030-09-068 - Development of a Shell-Core Modified Release Tablet via HME-Coupled 3D Printing for Oral Pulsatile Delivery

Favorite
M1130-11-085 - Development of a Stable Anticancer Formulation of BIO-X1: From Solution to Lyophilized Drug Product

Favorite
T1530-11-082 - Development of a Stable Anticancer Lyophilized Formulation of SMS-IV1 as an Intravenous Infusion

Favorite
W1030-12-094 - Development of a Stable Formulation for Stabilized HIV-1 Env Trimer Vaccine Candidate (HIV-1 Trimer 4571)

Favorite
W1030-12-096 - Development of a Stable High Concentration Formulation for Anti-malaria Antibody CIS43LS

Favorite
T1130-12-091 - Development of a Suspension-Type Transdermal Patch of Tenofovir Alafenamide

Favorite
M1330-11-084 - Development of an Acid Resistant Banding Solution for DRcapsTM

Favorite
W0930-08-057 - Development of an Aqueous Nanoformulation of Cannabidiol (CBD)

Favorite
M1430-07-051 - Development of an Improved Reversed-Phase HPLC Stability Indicating Method and Forced Degradation Studies of Curcuminoids

Favorite
T0930-08-057 - Development of an In Situ Gelling Collagen Drug Formulation

Favorite
M1130-07-053 - Development of an In Vitro Release Rate Test for Loteprednol in an Ophthalmic Suspension Using USP Immersion Cell Apparatus

Favorite
W1230-12-096 - Development of an In-Line Near-Infrared Method for Blend Content Uniformity Assessment in a Tablet Feed Frame

Favorite
T1230-11-086 - Development of Colon-Targeted ProRelease® Microparticle Formulation of a Discovery Candidate for Preclinical Studies

Favorite
M1030-09-072 - Development of Composite Microsphere Loading Doxorubicin Nanoparticle and 20(S)-Ginsenoside Rh2 for Drug Resistance Breast Cancer Treatment

Favorite
T1230-11-085 - Development of Controlled Release Oral Dosages by Density Gradient Modification Using 3D Printing Technologies

Favorite
M1130-09-071 - Development of Core-Shell Structured Controlled Release Oral Dosages Using 3D Printing Technologies

Favorite
W1230-10-079 - Development of Cough Cold Liquids

Favorite
W1130-11-086 - Development of Delayed-Release Pellets of Ibuprofen Using Kollicoat® MAE 100P via Hot-Melt Extrusion Technology

Favorite
M1230-11-088 - Development of Esculetin Nanocrystal: Toward an Innovative Approach for Hyperuricemia

Favorite
M1530-10-079 - Development of Fast Dissolving Film for Intra-Oral Delivery

Favorite
W0930-11-081 - Development of FDC Nanosuspension for Anti-HIV Therapy by Computational and Experimental Approach

Favorite
T1230-11-088 - Development of Floating Pulsatile Delivery System for Chronotherapy of Nocturnal Asthma Using Hot Melt Extrusion Coupled 3D Printing

Favorite
T1030-13-101 - Development of In Vitro Diffusion Method for Nasally Insufflated Abuse Deterrent Formulation

Favorite
T1130-13-097 - Development of In Vitro In Vivo Correlation (IVIVC) for Upadacitinib Extended-Release Formulation

Favorite
M1130-13-099 - Development of In Vitro-In Vivo Correlation for Complex Parenteral Microsphere Drug Products – Effect of Burst Release

Favorite
T1130-13-099 - Development of In Vitro-In Vivo Correlation of Peptide Microspheres – Possibility and Challenges

Favorite
W1230-11-088 - Development of Injectable Intramuscular Particulate Formulation of Anti-infective

Favorite
T1130-08-064 - Development of Insulin Solution Dosage Form for Sublingual Administration Using Design of Experiments Approach

Favorite
T1230-11-081 - Development of Microparticle Using Spray Drying and Emulsion Evaporation Technology for Colon-Targeted Oral Drug Delivery

Favorite
W1130-08-057 - Development of Nanocarriers for Cutaneous Delivery of H 2 S-Releasing Corticosteroids for Psoriasis Treatment

Favorite
T1030-10-076 - Development of Novel D-cycloserine-Loaded Tablet with Improved Drug Stability and Dissolution-Equivalence to the D-cycloserine-Loaded Commercial Hard Capsule

Favorite
M1430-13-098 - Development of Novel Flash Orally Disintegrating Tablet Dosage Forms

Favorite
M1230-08-057 - Development of Novel Ophthalmic Drug Delivery System of Pefloxacin with Increased Ocular Availability

Favorite
W0930-09-071 - Development of Novel Ultra-Long-Acting Injectable Combinatory Implants for Treatment of Osteoporosis

Favorite
M1430-11-086 - Development of Oral Gastro-Retentive Delivery System Using Immediate Floating Tablet Technology

Favorite
M1430-08-063 - Development of Platelet-Inspired Carriers for Targeted Thrombolytic Therapy

Favorite
W1130-07-053 - Development of Prolonged-Release Tablets with Thermoplastic Polyurethanes by Ultrasound Assisted Direct Compression

Favorite
M1230-12-093 - Development of Solid Lipid Nanoparticles using Hot Melt Extrusion for Pulmonary Delivery of Water Insoluble Drugs

Favorite
M1330-07-051 - Development of Stability Indicating RP-HPLC Method for an α-Amino Acid in a Topical Formulation Without Derivatization

Favorite
W1130-11-088 - Development of Stimuli-Responsive Polymersomes for Tumor Drug Delivery

Favorite
T1230-09-068 - Development of Sulfo-albumin as a Macromolecular Hydrogen Sulfide Prodrug for the Treatment of Reactive Oxygen Species-Mediated Disease

Favorite
W1230-09-070 - Development of Surface-Modified High Potency Nanoaggregates of Voriconazole Powders for Dry Powder Inhalation

Favorite
T1130-11-085 - Development of the Multi-layered Organic-Inorganic Hybrid Nanocomplex as an Effective Oral Delivery System of Protein Drugs

Favorite
T1430-12-092 - Development of Theophylline and Nicotinamide Co-crystals Utilizing Hot Melt Extrusion Technology

Favorite
M1530-08-064 - Development of Transdermal Patch of Tenofovir Alafenamide for HIV Prophylaxis and Treatment

Favorite
W1030-11-085 - Diclofenac Sodium Stability in Simulating Physiological Media and Its Entrapment Efficiency in MCM-41

Favorite
T1530-10-074 - Dimethlacetamide and a Novel Co-processed Excipient- A Promising Approach to Develop a Rapid Release Self-nanoemulsifying Tablet of Fenofirbate

Favorite
M0930-07-054 - Discriminating Dissolution Method for a HPMC Capsule Formulation Containing a BCS Class II/IV Compound with the Functional Excipient Tartaric Acid

Favorite
M1430-10-074 - Disintegration Testing of Botanicals (Green Tea and Turmeric) Dietary Supplements (DS): A Dietary Supplement Ingredient Database (DSID) Initiative

Favorite
T1430-09-066 - Dissolution Method Development for Assessing Amorphous Solid Dispersions

Favorite
M0930-07-052 - Dissolution Screening for Formulation to Mitigate PPI or H2-RAs Effect: Synergies of Biorelevant Media and On-Line Dissolution Monitoring

Favorite
M1130-07-049 - Dissolution Testing of Nifedipine ER Tablet Using the USP Flow-Through Method

Favorite
M1130-07-050 - Do All Solid Hydrophilic Carriers Enhance Dissolution Rates? An Investigation into the Relationship between Solid Hydrophilic Carriers and Their Effect on Dissolution Rates

Favorite
M1330-10-076 - DoE Based Systematic Development of Novel Optimized Solid Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Berberine with Enhanced Oral Bioavailability for Antihyperlipidemic Activity

Favorite
M1330-07-050 - Dose Content Uniformity Studies of Multi-dose Ophthalmic Suspension Drug Products as a Metric for Supporting the Quality and Equivalence of Complex Formulations

Favorite
M1030-10-073 - Drug Crystallization in Amorphous Solid Dispersions

Favorite
W0930-11-086 - Drug-Drug Ionic Liquids of Diphenhydramine with Ibuprofen and Naproxen–Discovery, Characterization, and Capsule Development

Favorite
W1230-09-071 - Dry Powder Fomulations of Newly-Developed Anti-Tuberculosis Drug Spectinamide 1599

Favorite
M1330-13-101 - Dual Functionalized Chitosan Nanomicelles Mediated Gene Delivery for Targeting Pro-Inflammatory Macrophages for the Treatment of Insulin Resistance

Favorite
W1230-07-054 - Dual-Effect Liposome Encapsulated with Irinotecan and Chlorin e6 to Improve Treatment Outcome of Resistant Pancreatic Cancer Cell Lines

Favorite
T1230-13-101 - Duality of Tumor Microenvironment on Biomimetic Nanoparticles

Favorite
T1230-10-075 - Dynamic Vapor Sorption and Raman Spectroscopy Investigation of Competitive Hydrate-Solvate Formation

Favorite
M1530-13-097 - Effect of Acidic Ternary Salts on Dovitinib/Cyclodextrin Solubilization and Complexation

Favorite
W1230-08-060 - Effect of Choosing Different Pressure Sensitive Adhesives on Performance Parameters of Lidocaine Patches

Favorite
M1030-13-101 - Effect of Co-administration of Foods and Drinks on the Dissolution of Paediatric Formulations–Case Study Mesalazine

Favorite
T1030-13-103 - Effect of Co-administration of Foods and Drinks on the Dissolution of Paediatric Formulations-Case Study Montelukast

Favorite
T1530-07-055 - Effect of Continuous Phase Properties on the Formation of PLGA Microparticles

Favorite
T1430-07-053 - Effect of Copolymer Concentration and Drug Loading on Release Profile of Insulin Incorporated in Thermosensitive Copolymer Based Delivery System

Favorite
M1030-13-100 - Effect of Different Model Compounds on γCD Apparent Critical Aggregation Concentration

Favorite
M1530-08-058 - Effect of Dosing Frequency on In Vitro Permeation of Trolamine Salicylate through Porcine Ear Skin

Favorite
T1130-10-078 - Effect of Drug Crystallization on In Vitro Performance of Testosterone Loaded Transdermal Delivery Systems

Favorite
M0930-10-080 - Effect of Drug Loading on Release from Amorphous Solid Dispersions Based on Water Soluble Polymers

Favorite
W1130-13-100 - Effect of Excipients on Physical Stability and Aerosol Performance of Spray Dried Amorphous DPI Formulations

Favorite
M1130-09-065 - Effect of Formulation Composition of Drug-Loaded Microemulsions on the Skin Retention and Permeation Through Microneedle Pretreated Skin

Favorite
T1530-09-067 - Effect of Formulation on the Disintegration of Spray-Dried Dispersion (SDD) and Co-Processed Intermediate (CPI) Tablets

Favorite
W1230-09-069 - Effect of Formulation Variables on Nasal Permeation and Stability of Naloxone in IItranasal Formulations

Favorite
T1230-07-052 - Effect of Hydroxypropyl-β-cyclodextrin on Dissolution and Flux of Poorly Soluble Drugs Using MacroFLUX

Favorite
T0930-08-061 - Effect of Implant Formation on Drug Release of In Situ Forming Implants

Favorite
T1130-07-053 - Effect of Manufacturing Process on Particle Morphology in Propofol Emulsions

Favorite
M1530-13-101 - Effect of Moisture and Temperature on Physical Stability of Amorphous Solid Dispersion

Favorite
M1030-10-078 - Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder

Favorite
T1330-07-056 - Effect of Particle Size and Size Distribution on Interfacial Properties of Liposomal Suspensions

Favorite
M1230-10-078 - Effect of Penetration Enhancers on Sublingual Permeability of Epinephrine

Favorite
T1130-07-055 - Effect of Physical and Chemical Factors on Transmission Terahertz Based Density Model

Favorite
M1130-11-082 - Effect of Relative Humidity on the Surface Energetics of Albumins

Favorite
T1030-13-098 - Effect of Simulated Gastrointestinal Contraction on Drug Release of Nifedipine Extended-Release Tablet

Favorite
M0930-11-087 - Effect of Surface Morphology on Very Low Dose API Mixing

Favorite
T1330-09-065 - Effect of Surfactant Level on Properties of Celecoxib Amorphous Solid Dispersion

Favorite
T0930-09-070 - Effect of the Ovalbumin after Transcutaneous Immunization by Dissolving Microneedle Arrays

Favorite
M0930-12-096 - Effect of Trisodium Citrate on the In Vitro Intestinal Permeability of Nutraceuticals

Favorite
M1230-10-073 - Effect of Various Polymers on Solubility and Dissolution Profiles of Mefenamic Acid via Hot-Melt Extrusion Technology

Favorite
M1430-12-089 - Effective Development and Validation of Dilution, Infusion, and In-Use Stability Studies of Pharmaceutical Drug Products

Favorite
M1230-08-060 - Effective Modulation of P-gp Activity in the Blood Ocular Barriers by Topically Administered Specific Inhibitors Improved Blood-Ocular Penetration of Anticancer Drug

Favorite
W0930-13-097 - Effects of Capsule Type on Water Content on a Model Compound

Favorite
T1430-07-055 - Effects of Drug Particle Size and Lipid Additives on the Melt Viscosity and Degree of Surface Drug Coating by Paraffin Wax in Spray Congealing

Favorite
M1330-11-085 - Effects of Drug-Polymer Interactions on Tablet Properties During the Development of Polyethylene oxide Containing Abuse-Deterrent Dosage Forms

Favorite
M1430-08-062 - Effects of Lyophilization and Nebulization on Stability of Single-Chain Tissue-Type and Single-Chain Urokinase Plasminogen Activator for Treatment of Inhalational Smoke-Induced Acute Lung Injury

Favorite
T1530-10-078 - Effects of Medium Chain Mono/Diglycerides on MDCK Cell Viability and Transport of Lipid Nanodroplets across MDCK Cell Monolayers

Favorite
T1530-10-075 - Effects of Molecularly Interacting Additives on Polymeric Hot Melt Extrusion

Favorite
W0930-13-099 - Effects of pH, Temperature and Storage Time on Susceptibility to Glass Particulates of Glass Vial: A Digital Microscopy Study

Favorite
T1030-11-087 - Effects of Solvents and Penetration Enhancers on Transdermal Delivery and Skin Deposition of Thymoquinone, an Anti-inflammatory Phytochemical

Favorite
T1330-13-104 - Efficient and Specific In Vivo Transfection of Neuronal Cells Mediated by Transferrin and Cell-Penetrating Modified Liposomes

Favorite
T1030-12-092 - Efficient Delivery of Paclitaxel for Therapy of Pancreatic Cancer

Favorite
T1330-10-079 - Efficient Drug Solubility Enhancement by Using Ultra-Low Molecular Weight HPC

Favorite
T1030-08-063 - EGF/Lysozyme Loaded Niosomes: A Potential Topical Therapy for Diabetic Foot Ulcer

Favorite
T0930-09-067 - Electrospun Chitosan/Polyethylene Oxide Nanofibers for Oromucosal Drug Delivery

Favorite
T0930-11-088 - Encapsulation of a Novel Silver Complex of Furosemide in Chitosan Nanoparticles for the Enhancement of Antibacterial Activity

Favorite
T0930-12-091 - Encapsulation of Berberine into Monoolein-Based Liquid Crystalline Nanoparticle Dispersion for Enhancement of Anticancer Activity

Favorite
T1330-08-059 - Encapsulation of Furosemide Silver Complex into Nanoparticles to Enhance Antibacterial Activity

Favorite
M1130-08-059 - Encapsulation of Resveratrol-Cyclodextrin Complex Loaded Nanoparticles for Enhanced Anticancer Effects on Non-Small Cell Lung Cancer Cell Lines

Favorite
T1430-08-057 - Endogenous Albumin-Mediated Delivery of Redox-Responsive Micelles for Targeted Cancer Therapy

Favorite
M1130-08-062 - Enhanced Bioavailability of Itraconazole by Two Different Methods of Solid Dispersions

Favorite
M1230-11-084 - Enhanced Dissolution Rate and Bioavailability of Poorly Water Soluble Fenofibrate Formulations by Melt-Adsorption Using Supercritical Carbon Dioxide

Favorite
T1330-11-083 - Enhanced Intra Tablet Enteric Coating Uniformity in the ConsiGma Coating Process

Favorite
M1330-09-069 - Enhanced Irbesartan Solubility through a Co-amorphous Formulation with Glimepiride

Favorite
T1330-08-058 - Enhanced Mucoadhesiveness and Thus Efficacy against Cervical Cancer by Cationic Functionalization of Imatinib Nanocrystals

Favorite
M1430-08-064 - Enhanced Permeation of Lipid-Core Micelles Printed on Mucoadhesive Films to Deliver Biologics through the Buccal Route

Favorite
T1230-09-065 - Enhancement of Aqueous Solubility, Dissolution and Permeability of Lurasidone Hydrochloride via Phospholipid Complexation

Favorite
M1530-11-085 - Enhancement of Gene Transfection Efficiency by the Use of Cell-Targeting Lipid Bubbles and Ultrasound

Favorite
M1530-10-078 - Enhancing Bioavailability of Abiraterone through Use of KinetiSol® Technology

Favorite
T1530-12-096 - Enteric Solid Dosage Formulation for Physiologically Active Proteins and Peptides

Favorite
T1430-12-096 - Enzymatic Site-Selective PEGylation of Proteins at Lysine or Glutamine by Transglutaminase

Favorite
T1130-08-060 - Enzyme Triggered Release of Entry Inhibitor for STD Prevention

Favorite
T0930-12-096 - EphA2 Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF V600E Mutated Parent and Resistant Melanoma Cancer

Favorite
T1530-12-093 - Establishment of In Vitro and In Vivo Correlation (IVIVC) Modeling Approach for Drugs with Narrow Absorption Window

Favorite
T0930-07-055 - Estimating Aggregate Concentration Precision in Nanoparticle Tracking

Favorite
M0930-07-056 - Estimating Intrinsic Solubility of Metastable Form of Drugs Using Modified Nogami Method

Favorite
T1030-12-091 - Etoposide Loaded Injectable Silk Gels for Local Treatment of Neuroblastoma

Favorite
W1030-13-101 - Eudragit-Based Microprecipitated Bulk Powder Formulations for Enhancing Oral Bioavailability of Sorafenib

Favorite
M1430-13-097 - Evaluating Disintegration Mechanisms that Improve Bioavailability from Immediate Release Tablets Using FBRM

Favorite
W1030-12-089 - Evaluating the Role of the Critical Micelle Concentration of Polysorbate-80 on Visible Particulate Formation after Agitation Stress

Favorite
W1230-13-104 - Evaluating the Stability of Polyvinyl Acetate Dispersion Coated Multi-Particulate Drug Delivery System

Favorite
T0930-11-086 - Evaluation and Optimization of a Topical Suspension Formulation

Favorite
T1030-07-050 - Evaluation and Prevention of an Unknown Impurity On-Column Formation in HPLC Impurity Analysis of an Active Pharmaceutical Ingredient

Favorite
M0930-11-084 - Evaluation of a Developmental High Productivity and High Gloss Film Coating System on the Final Appearance of Coated Tablets

Favorite
M1230-13-101 - Evaluation of a Gelatin-Doxorubicin Conjugate as an Agent of Lysosomal Membrane Permeabilization (LMP) in Breast Cancer Cells

Favorite
M1330-12-090 - Evaluation of an Ultra-High Speed High Gloss Film Coating System in the GEA ConsiGma™ Coater

Favorite
T0930-07-056 - Evaluation of Backgrounded Membrane Imaging (BMI) for iIs Application in the High-Throughput Analysis of Subvisible Particles

Favorite
M0930-13-098 - Evaluation of Bioavailability of Lidocaine and Prilocaine from Topical Drug Products Using an In Vitro Permeation Test (IVPT)

Favorite
M1230-09-068 - Evaluation of Biomimetic Ultra Thin Large Area Polydimethyl Siloxane Membranes in a Rationally Designed In Vivo Relevant Dissolution Apparatus

Favorite
T1230-10-078 - Evaluation of Chemical Stability of Naloxone Products beyond Their Labeled Expiration Dates

Favorite
T1430-10-078 - Evaluation of Coating Performance of Instacoat 4G™ on Tramadol Tablets in an Autocoater

Favorite
M1330-09-072 - Evaluation of Compound A Amorphous Solid Dispersion Dissolution in Biorelevant Dissolution Media

Favorite
W1130-10-074 - Evaluation of Cytotoxicity of Self-Emulsifying Formulations containing Long Chain Lipids Using Caco-2 Cell Model

Favorite
M1030-10-075 - Evaluation of HPMCAS-Nifedipine Solid Dispersion by DSC, XRD and Their Hyphenated Analysis DSC-XRD

Favorite
W1230-07-053 - Evaluation of Hydrogenated Castor Oil for a Controlled Release Multiparticulate Formulation Platform

Favorite
W1030-10-076 - Evaluation of Instacoat™ SFC ( Sugar Fast Coat) in an Autocoater

Favorite
T1530-11-087 - Evaluation of Instacoat™ SFC on Enzyme Tablets Using a Conventional Coating Pan

Favorite
M1230-12-091 - Evaluation of Intra-lysosomal Drug Release from a Gelatin-Doxorubicin Conjugate in MCF-7 Breast Cancer Cells

Favorite
T1330-10-080 - Evaluation of Oleic Acid and Polyethylene Glycol Monomethyl Ether Derivative as a Solubility Enhancer of Furosemide

Favorite
T1430-08-060 - Evaluation of Poly D, L Lactic Co-Glycolic Acid (PLGA) Nanoparticles Uptake Pathways across the Nasal Mucosa

Favorite
M1430-09-071 - Evaluation of Screening Tool for Amorphous Solid Dispersions Prepared Using EUDRAGIT® Polymers

Favorite
M0930-11-081 - Evaluation of Stabilization Effect of HPβCD and PVP on Bovine Serum Albumin (BSA) Spray-Dried (SDD) Formulation

Favorite
M1030-11-083 - Evaluation of Stabilization Effect of HPβCD, PVP, and NaCMC on Bovine Serum Albumin (BSA) Lyophilization Formulation

Favorite
M1030-13-099 - Evaluation of Sub-visible and Nano Particles Originating from Elastomeric Closures

Favorite
T1530-13-102 - Evaluation of the Internal and External Structure of Directly Compressed Polyethylene Oxide (PEO) Based Matrix Tablets Before and after Curing Using X-ray Micro-computed Tomography

Favorite
T0930-10-080 - Evaluation of the Sublingual pH-Permeability Profile of Epinephrine

Favorite
M1030-09-067 - Evaluation of Topical Pilocarpine Formulation for Stimulating Sweat Secretion for Cystic Fibrosis Diagnosis

Favorite
W1130-10-077 - Evaluation the Bitterness Masking Effect of Umami Peptides on Bitter Drugs by Taste Sensor Measurement and Human Sensation Test

Favorite
W1030-09-071 - Evaluations of Ease of Swallowing and Handling Tablets of Various Sizes in Healthy Volunteers and Elderly Patients

Favorite
W1130-10-079 - Excipient Consistency Is Key to De-risk Formulation Development and Manufacturing

Favorite
M1330-13-100 - Excipient Screening for the Protection of ABAB Antibody producing Saccharomyces boulardii for the Treatment of Clostridium Difficile Infection (CDI) during Spray Drying

Favorite
T1430-11-084 - Experimental Design Approach for Optimization of Monodisperse Polymeric Microparticles Using Modified Vibrating Orifice Aerosol Generator for Controlled Delivery of Letrozole in Breast Cancer Therapy

Favorite
M1230-07-051 - Exploring the Impact of Excipients on Formulation Properties Through Quality by Design

Favorite
M1230-08-064 - Extended Release of Protein to the Ocular Surface

Favorite
T1530-08-063 - Extractable Evaluation on Microneedle Patches

Favorite
W0930-13-103 - Extractable Study of Westar® Chlorobutyl Rubber Stopper

Favorite
T1330-11-082 - Extrudability Analysis of Drug Loaded Pastes for 3D Printing of Modified Release Tablets

Favorite
W1030-09-066 - Fabrication and Characterization of Controlled Release PLGA Microneedle for In Situ Prolonged Delivery of FITC-Dextran

Favorite
M1230-12-089 - Fabrication of Metformin Loaded PLGA Microparticles Using Double Emulsion Solvent Evaporation Method: A Design of Experiment Study

Favorite
T1030-09-067 - Fabrication of Novel PLGA Nanoparticles for Anticancer Peptide Delivery

Favorite
W0930-08-064 - Fabrication, Evaluation and Antioxidant Activity of Caffeine Fast Melt Tablets

Favorite
M1130-11-083 - Factors Governing the Reconstitution Time of Highly Concentrated Lyophilized Proteins in Amorphous Formulations

Favorite
T1030-09-072 - Fate of Biodegradable Microneedles In Vivo – A Mechanistic Insight

Favorite
W1130-10-078 - Feasibility of High-Dose OD Tablets Containing API which has Low Compressibility

Favorite
T1030-12-093 - Finding the Right Fit: Comparison of In Vitro and In Vivo Performance of Different Modified Release Formulation Platforms

Favorite
M1130-12-091 - FKBP Elastin Like-Polypeptide Fusion Carriers Facilitate Intracellular Delivery of Rapamycin by Macropinocytosis

Favorite
T0930-07-054 - Flow-Imaging Microscopy Goes Submicron – A Feasibility Study with Relevant Biopharmaceutical Drug Products

Favorite
T1130-11-086 - Fluorescence and Light Scatter Distinguish Different Degrees of Perturbations in Proteins

Favorite
M1530-07-050 - Focused Ion Beam Etching as a Technique for Submicron-Imaging of Lipid Multiparticulates

Favorite
T1130-09-072 - Formulating Extended Release Drug Pellets Using CPS™ Technology

Favorite
W1030-09-072 - Formulation and Characterisation of Metronidazole Buccal films

Favorite
T0930-12-090 - Formulation and Characterization of Albumin/Glycine Microspheres Encapsulated with Resveratrol as a Model Drug

Favorite
W1230-11-087 - Formulation and Characterization of Curcumin Loaded Polymeric Micelles Produced via Continuous Processing Using Co-Axial Jet in Co-flow Technology

Favorite
W0930-12-092 - Formulation and Characterization of Nanoparticles for Poorly Soluble Compounds against Cataract and Assessment of Their Antioxidant Activity by Chemical and Biochemical Assays

Favorite
W1130-13-101 - Formulation and Characterization of Spray Dried Pyrazinoic Acid Dry Powder toward Inhaled Therapies of Tuberculosis

Favorite
M1530-08-060 - Formulation and Evaluation of 4-benzylpiperidine Drug-in-Adhesive Matrix Type Transdermal Patch

Favorite
T1030-11-081 - Formulation and In Vitro Evaluation of a New Mucoadhesive Mouthwash

Favorite
M1330-10-077 - Formulation and In vitro Evaluation of Dronedarone HCl Ternary Mixture Formulations

Favorite
T1330-13-100 - Formulation and In Vitro Evaluation of Spray-Dried Hydrogel Containing Sildenafil Citrate for Pulmonary Drug Delivery

Favorite
T1530-13-098 - Formulation and Optimization of Oil/PEG Cream by Hot Melt Extrusion Technology

Favorite
W1030-07-053 - Formulation and Pharmacokinetics of Multi-layered Matrix Tablets: Biphasic Delivery of Diclofenac

Favorite
M0930-11-082 - Formulation and Stability of Lysozyme

Favorite
M1030-11-084 - Formulation Design Space Assessment for a Humanized IgG1 Monoclonal Antibody

Favorite
M1330-10-079 - Formulation Development and Evaluation of Ticagrelor Loaded Self-emulsifying Drug Delivery System (SMEDDS)

Favorite
T1230-08-057 - Formulation Development and In Vitro Characterization of Axitinib Loaded Polylactic-co-Glycolic Acid (PLGA) Nanoparticles

Favorite
T1330-11-084 - Formulation Development and Pharmacokinetics of OJT001 Loaded Solid Lipid Nanoparticles

Favorite
M1130-12-090 - Formulation Development, cGMP Manufacturing and Characterization of a Novel Transdermal Formulation for E/Z-Endoxifen

Favorite
T1130-12-092 - Formulation of a Hydroxypropyl Methylcellulose Gel Embeded with Nicotine Conjugate Loaded Solid Lipid Nanoparticles and Its Evaluation as a Transdermal Delivery System

Favorite
T0930-10-078 - Formulation of Aripiprazole-Loaded pH-Modulated Solid Dispersions via Hot-Melt Extrusion Technology: In Vitro and In Vivo Studies

Favorite
W1230-09-067 - Formulation of Gefitinib Loaded Nanostructured Lipid Carriers (NLC): Methods to Improve Drug Loading into the Lipid Core of NLC’s

Favorite
M1130-10-075 - Formulation of HPMCAS-based Solid Dispersions Prepared by Hot-Melt Extrusion: Polymer-Drug-Surfactant Miscibility, Extrudability, and Effect of Surfactants on Drug Release

Favorite
T0930-11-082 - Formulation of Lipid Based Tableted Spray-Congealed Microparticles for Zero Order Release of Vildagliptin

Favorite
W0930-11-085 - Formulation of Rapidly Disintegrating Tablets with High Bitter Drug Load and High Tensile Strength

Favorite
T1530-11-088 - Formulation of ST-001 Nanosuspension

Favorite
T1230-09-072 - Formulation of Tadalafil Loaded PLGA Nanoparticles for Non-Invasive Pulmonary Delivery

Favorite
T1230-08-061 - Formulation Optimization and Ocular Pharmacokinetics and Toxicity Investigations of Insulin-Loaded Thermoresponsive Biodegradable Nanogels Intended for the Treatment of Diabetic Retinopathy

Favorite
M1030-08-063 - Formulation Optimization of BDNF siRNA Loaded Lipidoid-Nanoparticles for Chronic Pain Therapy

Favorite
T1330-13-101 - Formulation Optimization of Spray-Freeze Dried Sildenafil Citrate Large Porous Microparticles for Pulmonary Drug Delivery

Favorite
M0930-11-085 - Formulation, Rheological and Mechanical Characterization of Soluplus®/Vitamin E Blends

Favorite
W1130-09-067 - F-Protein Virus Like Particle Microparticulate Vaccine for RSV Infection: In Vitro and In Vivo Immunogenicity Evaluation

Favorite
T0930-13-099 - Frequently Observed Deficiencies in Abbreviated New Drug Applications (ANDAs) Related to Analytical Method Validation/Verification/Transfer

Favorite
M0930-13-102 - Frequently Observed Deficiencies in Refuse-to-Receive Abbreviated New Drug Applications

Favorite
M1030-07-053 - Functional Characterization of Excipients Used in Solid Oral Dosage Forms by UV-Vis Dissolution Imaging

Favorite
T1430-11-082 - Gastric Gloating Drug Delivery Systems of Metoprolol Succinate Using Non Effervescent and Effervescent Approaches - Design and Biopharmaceutical Evaluation

Favorite
M1430-10-078 - Gelucire 48/16®: A Versatile Non-Ionic Solid Solubilizer for Tablets of Poorly Water-Soluble Drugs

Favorite
M1230-13-104 - Gene Delivery through GLUT-1 and Penetratin Targeted Nanoparticles to Brain: In Vitro Characterization for Particles Size, Charge, Cell Uptake and Transfection Efficiency

Favorite
M1330-09-067 - Hansen Solubility Parameters as Predictors of Miscibility in Amorphous Solid Dispersions

Favorite
T1030-08-064 - Harnessing Fibroblast Growth Factor-Inducible 14 (Fn14) for Targeting Metastatic Triple Negative Breast Cancer

Favorite
M1030-08-062 - Hemopressin-Based pH-Sensitive Hydrogel: A Potential Bioactive Platform for Drug Delivery

Favorite
T1530-07-053 - High Diffusivity Peptides as Drug Carriers through Tumor Extracellular Matrix

Favorite
T1530-07-052 - High Intensity Focused Ultrasound (HIFU)-Triggered Liposomal Drug Release Using Acoustic Cavitation Effect

Favorite
M1130-07-056 - High Levels of Acidic Variants Caused by Carbonylation in Manufactured Monoclonal Antibody Batches

Favorite
T1530-09-066 - High Loaded Amorphous Nanoparticles for Delivery of Very Low Solubility Compounds

Favorite
T1130-09-071 - High Pressure Homogenization as a Potential Approach to Formulate Amodiaquine Nanoparticles and Exploring Their Efficacy in Non-Small Cell Lung Cancer

Favorite
W0930-10-079 - High Solids Loading in HPMCAS Spray Dry Solutions and Effects on Solid Dispersion Morphology

Favorite
W0930-07-056 - High Temperature Measurement of API Solubility in Organic Solvents for Spray-Drying Process Development

Favorite
T1030-11-083 - High Throughput Screening and Chemical Sparing Approach To Emulsion Formulation Development through Acoustic Mixing

Favorite
M1530-10-075 - High Throughput Screening for the Discovery of Self-Emulsifying Drug Delivery Systems (SEDDS)

Favorite
M1430-12-093 - High-Efficiency Method to Load Protein Drugs into Exosome while Keeping Innate Exosome Properties

Favorite
T1130-13-101 - Highlights of Biopharmaceutics Review Good Practices for Setting Clinically Relevant Specifications for Drug Substance’s Particle Size, based on PBPK Absorption Modeling and Simulation

Favorite
T1230-13-100 - Highly Porous Bilayer Tablets for Enhanced Gastroretentive Properties and Easy Formulation Development.

Favorite
W0930-12-096 - High-Throughput Formulation Screening to Study Skin Retention Using Two-Photon Microscopy

Favorite
W0930-11-084 - Hot-Melt Co-extrusion Technology as a Manufacturing Platform for Anti-hypertensive Fixed-Dose Combinations

Favorite
T1330-13-103 - How Does the Presence of Particles affect the Plume Characteristics of Nasal Sprays?

Favorite
M1530-09-072 - How Drug Solubilizing Agents Modulate Cocrystal Supersaturation Index and Manage Phase Transformations

Favorite
W0930-12-089 - Hydrophobic Impurities Cause Measurable Changes in the Physico-Chemical Behavior of Poloxamer 188

Favorite
T1130-10-080 - Ibuprofen/Microcrystalline Cellulose Percolation Threshold - Impact on Tablet Dissolution Process

Favorite
M1130-12-095 - Identification and Optimization of Critical Process Parameters of Roller Compacted Capsules: from Development to Registration Batches

Favorite
T0930-07-049 - Identification and Quantitation of Residual Monomers in PLGA Copolymers

Favorite
T1130-11-087 - Identification of Drug Substance Charge Variants of a Monoclonal Antibody Involved in Aggregation Formation

Favorite
M1130-13-097 - Identification of the Potential Culprits of Adverse Effects for Warfarin Generic Products Using PBPK/PD Modeling Approach

Favorite
T1130-07-050 - Identify Your Limits: Definition of Spray Drying Tout Based on a Novel Methodology to Measure Powder Stickiness

Favorite
W0930-08-062 - Imaging-Guided Targeted Drug Delivery Using Stimuli-Sensitive Theranostic Nanoparticles: Characterization and In Vivo Trafficking Patterns

Favorite
T1130-10-076 - Impact of Acetaminophen Crystal Size on In Vitro Performance of METHOCEL Premium DC2 HPMC Matrix Tablets

Favorite
T1430-10-077 - Impact of Excipients Commonly Used in Lipid-Based Drug Delivery Systems on Softgels Performance

Favorite
M1430-09-069 - Impact of Formulation Parameters on Tablets Containing a High Level of Amorphous Solid Dispersion Prepared by Hot Melt Extrusion

Favorite
W1030-11-084 - Impact of Hydroxyl Value of Fatty Acid Based Suppository on Condom Compatibility

Favorite
M1130-10-076 - Impact of Method of Preparation on the Morphology and Mechanical Properties of Amorphous Solid Dispersion: Comparison of Co-precipitation and Spray Drying

Favorite
M0930-10-079 - Impact of Microstructure on the Dissolution Performance of Amorphous Solid Dispersions

Favorite
W1030-12-092 - Impact of Processing Conditions and an Amorphous Co-solute on the Phase Behaviors of Poloxamer 188 Aqueous Solutions during Freezing and Thawing

Favorite
M0930-10-077 - Impact of Temperature Relative to the Glass Transition Temperature on the Dissolution Performance of Anacetrapib-Copovidone Amorphous Solid Dispersions

Favorite
M1130-10-079 - Impacts of Polymers on Crystal Nucleation and Growth of Indomethacin from Supersaturated Solutions

Favorite
T1430-10-073 - Improved Functional Properties of Fine Excipients and Blends via Dry Coating with Nano-Particles

Favorite
T1530-11-086 - Improved Palatability of Gummi Drug of Epinastine Hydrochloride Using Organoleptic Taste-Masking Methods

Favorite
M0930-11-086 - Improved Plasdone S630: A New Grade of Copovidone with Enhanced Properties for Hot Melt Extrusion (HME) Process

Favorite
W1030-12-095 - Improved Understanding of Protein Interactions in Formulation Development Using Liquid Cell Electron Microscopy

Favorite
W0930-13-100 - Improvement of Extraction Efficiency and Quantification Accuracy for the Analysis of Volatile Organic Compounds Extracted from Pharmaceutical Contact Materials

Favorite
M1430-07-049 - Improvement of HPLC Method Parameters to Solve an Antibiotic Analog Compound Anomalous Behavior

Favorite
M1330-09-070 - Improving Bioavailability by Co-crystal Formation: An Aprepitant Story

Favorite
M1330-11-088 - Improving Hydrophilic Drug Loading and Dissolution Rate of 3D Printed PVA Based Tablets

Favorite
M1030-11-082 - In Silico Discovery of Potential Excipients for Novel Antibodies

Favorite
M1030-07-052 - In Situ Fiber Optic Dissolution Monitoring of Combination Drug Product Containing Three Actives

Favorite
T1230-07-056 - In Situ Mechanical Raman Spectroscopy for Monitoring of Chlorpropamide Polymorphic Transformation during Tableting

Favorite
M1230-10-080 - In Vitro Evaluation of Nanocrystals for Enhancing Bioavailability of a P-glycoprotien Substrate Drug as Atorvastatin Calcium

Favorite
M1130-09-068 - In Vitro and In Vivo Evaluation of Two Lidocaine Topical Delivery Systems With or Without the Influence of Transient Heat Exposure

Favorite
T1330-12-096 - In Vitro Assessment of Natural Products in Murine Macrophages for the Treatment of Chronic Inflammation

Favorite
M1530-08-062 - In Vitro Dermatokinetic of Silymarin in Human Skin Models

Favorite
M1030-07-051 - In Vitro Dissolution and In Silico Simulation to Evaluate Intestinal Precipitation and Supersaturation of a Weakly Basic Pharmaceutical Compound

Favorite
M1530-09-070 - In Vitro Dissolution Investigations of Novel Solid Dispersions Using Sodium Alginate, Surfactants and a BCS IV Drug

Favorite
M1530-10-080 - In Vitro Dissolution-Permeation Study to Characterize Itraconazole Formulations: The Effect of Formulation Additives, Food and Dose

Favorite
W1130-09-069 - In Vitro Evaluation of Porin Encapsulated Chitosan Nanosystems for Mucosal Vaccine Delivery

Favorite
M1130-09-069 - In Vitro Permeation Behaviour of a Novel Tyrosinase Inhibitor Investigated by Human Skin, Porcine Skin, and an Artificial Skin Model

Favorite
M1030-09-071 - In Vitro Permeation Testing to Evaluate the Combined Permeation Efficiency of Immediate and Delayed Application of Two Topical Ointment Formulations for the Treatment of Psoriasis

Favorite
W1030-07-051 - In Vitro Release and Pharmacokinetics of Mebeverine HCl Floating Delivery Systems in Beagle Dogs

Favorite
M1230-07-049 - In Vitro Release Test (IVRT) Comparisons of Six Acyclovir Cream, 5% Products to Evaluate the Impact of Compositional Differences on Product Performance

Favorite
M1130-07-054 - In Vitro Release Testing Method Development for In Situ Forming Gels

Favorite
W1130-13-104 - In Vitro Release Testing Methods for Long-Acting Intrauterine Systems

Favorite
T0930-10-075 - In Vivo Evaluation of a Cefuroxime Axetil Gastro-Retentive Floating Drug Delivery System Prepared by Hot-Melt Extrusion Technology

Favorite
M1030-11-087 - In Vivo Evaluation of Lipid Coated Magnesium Phosphate Nanoparticles for Intracellular Protein Delivery

Favorite
W1130-13-099 - Incorporation of Colistin in the Spray Dried Ciprofloxacin Improves Physical and Aerosolization Stability of Dry Powder Inhaler Formulations

Favorite
T1530-11-085 - Incorporation of Lipophilicity to Proteins and Peptides

Favorite
T1130-09-069 - Increased Intracellular Uptake of Serum Albumin Nanoparticles in Oncogenic KRAS Cancer Cells

Favorite
T1030-09-071 - Increasing Therapeutic Potency of Extracellular Vesicles via Novel Loading Mechanisms

Favorite
W0930-09-070 - Indocyaine Green-Chitosan Nanoparticles-Loaded Dissolving Microneedles for Melanoma Photothemal Therapy

Favorite
M1530-12-093 - Influence of Anti-static Agent Addition on the Excipient Powders Behavior

Favorite
T1430-13-101 - Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D Printed Tablets

Favorite
M1330-10-078 - Influence of HPMC and SLS on the Solubility and Dissolution of Sirolimus in Solvent-Evaporated Solid Dispersions

Favorite
M1430-11-087 - Influence of Kollicoat MAE 100-55, a Novel Polymer for Taste Masking via Hot Melt Extrusion Technology: Impact of Pore Formers

Favorite
T1430-09-068 - Influence of Mechanical and Thermal Energies on Nifedipine Amorphous Solid Dispersion Prepared by Hot Melt Extrusion

Favorite
M1230-10-074 - Influence of Mesoporous Silica Properties on Drug Loading Capacity

Favorite
T1430-10-079 - Influence of Micronized HPC on Dynamic Powder Flow

Favorite
M1330-11-086 - Influence of Processing Variables on Solid-State Stability and Dissolution of Phenytoin Sodium Extended Release Capsule

Favorite
W1230-11-086 - Influence of Sulfobutylether-β-Cyclodextrin on Intravenous Pharmacokinetics of Silymarin

Favorite
M0930-12-089 - Influence of the Adsorbent Types on the Dissolution of Poorly Water Soluble Drug Cinnarizine from Lipid-Based Self-emulsifying Formulations

Favorite
W1130-13-097 - Inhalation Delivery of Bio-inspired Tofacitinib Loaded Liposomes: Formulation and evaluation

Favorite
M1030-09-065 - Inhibition of Anandamide Metabolism in In Vitro Human Skin Model

Favorite
T1530-07-051 - Injectable Poly(lactic-co-glycolic acid) Microspheres for One-month Controlled Release of Etonogestrel

Favorite
T1130-09-065 - Injectable Self-Healing Gel with Controlled VEGF Release for Induced Angiogenesis

Favorite
T1530-13-099 - Inkjet-Based 3D Printing of Solid Oral Dosage Manufacturing

Favorite
T1130-10-075 - Inline Raman Monitoring and Analysis of Carbamazepine Polymorphic Form Transformation Using Twin Screw Extrusion (TSE) Platform

Favorite
W1130-09-070 - Insoluble Aluminum Salt-Adjuvanted Vaccine Dry Powder Prepared by Thin-Film Freeze-Drying is Suitable for Intranasal Administration

Favorite
M1330-07-052 - Interactions of Solubilizer, Formulation pH and Preservative: A Case Study of Pediatric Oral Solution Formulation Stability

Favorite
T1330-10-078 - Introduction of CREA-IM as Anti-segregation Agent for Levothyroxine

Favorite
M1230-12-095 - In-Use Stability for a Drug/Device Combination of Solid Multiparticulates for Oral Delivery to the Pediatric Population

Favorite
M1530-08-059 - Investigate the Impact of Homogenization as a Scale up factor on Rheological properties from Hydroxypropyl cellulose Topical gel

Favorite
M1130-09-066 - Investigating Drug Loading Capacity of TyroSpheres, a Polymer-Based Nanocarrier System for Use in Dermal Delivery

Favorite
M1030-13-103 - Investigating Factors That Affect In Vitro Drug Release From A Parenteral Liposomal Formulation

Favorite
T1530-09-072 - Investigating the Applicability of the Molecular Descriptor R3m in Predicting Amorphous Solid Dispersion formation in Different Polymers

Favorite
W1230-10-074 - Investigating the Effect of Processing Magnesium Stearate on Indomethacin Tablet Dissolution

Favorite
T1330-10-077 - Investigating the Impact of Extruder Process Parameters and Rotation Mode on HPMCAS Degradation

Favorite
W1030-12-090 - Investigating the Influence of Polysorbate 20/80 and Polaxomer P188 On Bovine Serum Albumin and Lysozyme Aggregation, Rheology & Interfacial Properties

Favorite
T1330-09-069 - Investigating the Relationship between the Molecular Descriptor R3m and API-Polymer Miscibility

Favorite
T1030-13-097 - Investigating the Solubility of Poorly Soluble Compounds in Biorelevant Media Simulating Patients with Ulcerative Colitis

Favorite
T1430-13-100 - Investigation into the Internal Structure of Coated Microparticles to Support Formulation and Coating Process Development

Favorite
M0930-07-049 - Investigation of a Small Volume Dissolution Method to Simulate Mouth Cavity Condition for Taste-Masking Evaluation of Dextromethorphan - Resin Complex

Favorite
M1230-07-052 - Investigation of Excipient Variability on Dissolution of a Highly Soluble Compound from Immediate Release Formulations

Favorite
M1030-12-095 - Investigation of Intrinsic Dissolution Rate (IDR) of a Free Base and Salt Form as a Function of pH to Study Salt Disproportionation Risk via Surface Dissolution UV-Imaging System

Favorite
W0930-09-069 - Investigation of Ligand Size on Targeted PLGA Nanoparticles for HER2 Breast Cancer: Whole Anti-HER2 Antibody and Its ScFv

Favorite
M1230-11-083 - Investigation of MCC and HPMC on Drug Dissolution of Tablet Prepared by Direct Compression

Favorite
W1230-13-100 - Investigation of Optimum Coating Conditions for an Easy Swallow Coating System

Favorite
M1430-09-068 - Investigation of Photostability of Curcumin via Cocrystallization with Polyphenols

Favorite
M1130-10-078 - Investigation of Polymer-Assisted Pharmaceutical Cocrystals Produced via Hot Melt Extrusion Technology

Favorite
M1530-12-094 - Investigation of Polyox Aqueous Granulation Using Fluid Bed Processor- Top Spray Method

Favorite
T1430-08-062 - Investigation of the Effect of Injection Rate and Performance While Injecting Highly Viscous Polymeric Fluids Mimicking Concentrated Biopharmaceuticals into Tissues

Favorite
T1230-10-079 - Investigation of the Physical Properties of Drug-Excipient Tablets Comprising Powders Produced by Co-Spray Drying

Favorite
W0930-13-098 - Investigation On Opalescence Phenomenon During Cleaning Of Aluminum Container Used For Excipient Fractioning

Favorite
T0930-07-053 - Investigations into Octyldodecanol (Kollicream® OD) Behavior in Skin by Spectroscopic Methods

Favorite
T1430-08-059 - Investigations of Inter-Particle Interactions between API-Excipient for Improvement in Demixing of DPI Formulation

Favorite
W1230-08-059 - Iontophoretic Delivery of Donepezil through Skin Treated by Microneedles and Laser

Favorite
T1530-09-071 - KinetiSol® Dispersing Enables Homogeneous Dispersion of Amorphous API in a Polymeric Carrier

Favorite
T1230-07-049 - Laser Diffraction Analysis of Supersaturated Solutions and Application to Screening of Amorphous Dispersions

Favorite
M1030-12-096 - Laser Head Space Analysis of Oxygen Concentration in a Capsule without Destruction of the Shell

Favorite
W1130-08-064 - Laser-based powder delivery as a versatile transdermal drug delivery platform

Favorite
T1330-08-062 - Leveraging Decreased Non-specific Adhesivity, Receptor-Targeted (DART) Nanoparticles for Treatment of Invasive Brain Tumors

Favorite
M1530-07-051 - Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles for Tumor Penetration

Favorite
T1030-07-054 - Life-time Stability of Size Exclusion Chromatography Columns for Quality Control of Therapeutic Protein Aggregates

Favorite
T1030-08-058 - Lipid Encapsulated Metformin as an Emerging Potential Drug Delivery System for Breast Cancer Treatment

Favorite
M1330-13-104 - Lipid Multiparticulates: A Rapid, Material-Sparing Technology for Early Clinical Development

Favorite
M1330-08-063 - Liposomal Homogenisation Using Microfluidizer® Technology Produces Stable Vesicles with High Entrapment of Amphotericin B

Favorite
M0930-08-061 - Long-Acting Formulations for Intraductal Delivery to the Breast

Favorite
M1330-08-057 - Long-Acting PLGA Microparticles of SNAP, an NO Donor, for a Protracted Reduction of Pulmonary Arterial Pressure in PAH

Favorite
W1030-13-102 - Low Temperature Fused Deposition Modeling (FDM) 3D Printing of Thermolabile Drugs

Favorite
W1130-11-084 - Low-Temperature Selective Laser Sintering 3D Printing of Drug-Loaded Gyroid Lattices

Favorite
T1130-09-070 - L-serine-Modified Polyamidoamine Dendrimer as a Highly Potent Renal Targeting Drug Carrier

Favorite
T1430-08-064 - Lucifer Yellow as a Paracellular Permeability Marker in a Cell Model of the Human BBB for DNA Nanoparticle Delivery.

Favorite
T1130-12-096 - Magnetic Nanoparticle and Field Systems for Treating Oral Caries Biofilms

Favorite
M1030-08-059 - Manufacture and Characterization of Aptamer-Functionalized Nanocarriers for Enhanced Cellular Internalization

Favorite
W0930-11-088 - Manufacture of a Fixed Dose Combination Product for the Treatment of Type II Diabetes by Hot Melt Continuous Granulation

Favorite
T1430-13-099 - Manufacturing of Liposomal Antibiotic Formulations Using High-Throughput Microfluidics Technology

Favorite
T1130-13-103 - Mass Transport Analysis of Bicarbonate Buffer in an In Vitro System, Investigating the Effect of Hydration and Dehydration Reaction Rates of Carbon Dioxide and Carbonic Acid

Favorite
T1530-10-080 - Measurement of the density distributions in ribbons containing paracetamol and various excipients by x-ray µCT and correlation to the minimum solid fraction

Favorite
T1130-13-100 - Measuring Fasted State Gastric Motility Before and After a Standard BA/BE 8oz Drink of Water: Validation of New MRI Imaging Protocols against Concomitant Perfused Manometry in Healthy Participants

Favorite
W1030-10-074 - Mechanical Properties of Polyethylene Oxide Formulated Tablets for Abuse Deterrent Formulations

Favorite
W1230-10-075 - Mechanism to the Reduced Dissolution of Ritonavir by Sodium Lauryl Sulfate

Favorite
T1430-13-097 - Mechanistic Model on pH-Dependent Dissolution of Diclofenac Sodium Extended-Release Tablets

Favorite
T1430-09-071 - Mechanistic Study of Release from Ledipasvir-Copovidone Amorphous Solid Dispersions Using Surface Area Normalized Dissolution

Favorite
M1130-07-055 - Mechanistic Understanding of In Vitro Drug Release of Bupivacaine from Multivesicular Liposomes

Favorite
T1430-12-091 - Mefenamic acid – HPMC AS HG amorphous solid dispersions: Site specific dissolution enhancement using Hot Melt Extrusion Technology

Favorite
M0930-10-078 - Melt Crystallization of Amorphous Pharmaceuticals, from Polymorphism to Physical Stability

Favorite
M1430-09-066 - Melt Crystallization of Griseofulvin/Poly (ethylene oxide) Dispersions: the Enrichment of Polymer at the Crystal-amorphous Interface

Favorite
T1430-13-098 - Melt Processes Used for the Production of Controlled Release Particles

Favorite
W1130-07-049 - Mesoporous Silica Nanoparticles with ROS-Responsive Gatekeepers for MR Imaging-Guided Photodynamic Chemotherapy

Favorite
M1130-12-092 - Metformin Formulation Using Microfluidic Double Emulsions

Favorite
W1230-10-080 - Metformin HCl formulation by continuous direct compression

Favorite
T0930-13-097 - Method Development and Optimization of an In Vitro Permeation Test (IVPT) to Compare the Rate and Extent of Drug Permeation from Topical Drug Products

Favorite
M0930-08-060 - Microbiological Evaluation of Gamma Radiation and Microwave Sterilized Grafts for Periodontological Applications

Favorite
T1330-10-074 - Microemulsion as Potential Ocular Drug Delivery Systems: Phase Diagrams and Physical Properties Depending on Ingredients

Favorite
W1230-08-057 - Microemulsion Formulations for Dermal Delivery of Amitriptyline Free Base

Favorite
T1430-12-095 - Microevaporative dispersion as a predictor of dissolution performance of amorphous dosage forms

Favorite
W1230-07-056 - Microfluidics-based Manufacture of PLGA Nanoparticles and Microparticles for use as Drug Delivery Vehicles.

Favorite
T1230-12-090 - Microscopic imaging and Colorimetric Techniques to Evaluate Surface Characteristics of Degradable 3D Printed Scaffolds for Dermal Regeneration

Favorite
M0930-13-097 - Microstructural Mapping of Dry Powder Inhalers (DPIs) Using Morphologically Directed Raman Spectroscopy (MDRS): A Novel Analytical Tool for DPI Characterization

Favorite
T1230-08-059 - Microwave synthesis of biodegradable poly(β-amino ester) based nanoparticles for ocular delivery

Favorite
W0930-07-050 - Miniaturized Methodology of Polymer Screening for Spray Dried Dispersions

Favorite
T0930-12-095 - Modification of Drug Release Properties of Liposomes by Tricaprin Incorporation

Favorite
T1430-11-083 - Modified Release Coated Soft Gelatin Capsules Dissolution and Physical Stability

Favorite
T1230-11-087 - Modified Release Coated Soft Gelatin Capsules Dissolution Stability

Favorite
T0930-13-102 - Moisture Vapor Transmission Study to Support a Lyophilized Vial Dosage Form

Favorite
M1230-12-096 - Molecular Engineering of Peptide-Modified Gemini Surfactants as Non-Invasive Cutaneous Gene Delivery Vectors

Favorite
M1530-09-066 - Molecular Interaction between Rafoxanide and Povidone for Amorphous Solid Dispersion Preparation

Favorite
T1430-12-090 - Molecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole

Favorite
W0930-10-075 - Molecular Origin of Plasticizing Effects of Lattice Water in Oxalic Acid Crystals

Favorite
T1230-08-062 - MRP1 Efflux Protein Expression Restricts the Penetration of Methotrexate Across the Blood Ocular Barriers: Effect of Specific Inhibitors

Favorite
M1030-08-064 - Mucus-penetrating peptides for improved transport across human cystic fibrotic sputum

Favorite
W1130-07-052 - Multifunctional Nanoparticles as Somatostatin Receptor-Targeting Delivery System of Polyaniline and Methotrexate for Combined Chemo–Photothermal Therapy

Favorite
T1230-12-095 - Multiparticulate drug delivery system for physiologically active proteins and peptides

Favorite
T1030-08-062 - Multi-scale Imaging Using Förster Resonance Energy Transfer for Evaluating Drug Carrier Distribution

Favorite
T1230-09-069 - Nanoclay-Reinforced Osteomimetic Matrices for Bone Tissue Engineering Applications

Favorite
W1030-13-098 - Nano-enabled Fast-Dissolving Orodispersible Films for Buccal Candidiasis

Favorite
M1530-11-088 - Nanoencapsulation of Ferulic Acid to Stabilize in Skin Care Formulations

Favorite
M1330-10-073 - Nanoparticle Formulations Prepared via Flash NanoPrecipitation for Enhanced Bioavailability and Stability

Favorite
T1230-13-099 - Nanoparticulate Neuropeptide Formulations for Sustained Delivery and Brain Targeting

Favorite
W1130-07-055 - Nano-Structured Liquid Crystalline Materials as Infection Responsive Delivery Systems

Favorite
M1130-10-080 - New Workflows for the Evaluation of Solid-forms of Active Pharmaceutical Ingredients in a Formulation

Favorite
M1330-11-087 - Non-Effervescent Floating Tablets of Pregabalin Using Sintering Technique

Favorite
M1530-12-089 - Nonlinear Regression Analysis in Powder Compaction: Application and Identification of Best Fit Models

Favorite
T1030-12-095 - Non-Uniform Drug Distribution Matrix system (NUDDMat) for achievement of zero-order release of drugs with different solubility

Favorite
T0930-10-077 - Novel Approaches for Evaluating and Enhancing Oral Absorption of Peptides

Favorite
W0930-11-087 - Novel Combination Nanodrug Regimen for Synergistic Chemoprevention of Pancreatic Cancer

Favorite
M1030-08-057 - Novel Liquid Anticoagulant Formulation for Oral Delivery in Paediatric Patients and Parenteral Delivery in Emergency Cases; Characterization and Pharmacodynamics Study

Favorite
W0930-07-051 - Novel Method of Disintegration and Breakup for Orally Disintegrating Tablets (ODTs): Simulation of Oral Milieus

Favorite
W1130-09-071 - Novel Microparticulate Vaccine Formulation for the Treatment of Metastatic Breast Cancer

Favorite
T0930-09-065 - Novel Peptide-Enhanced Endostatin-Loaded Nano-Cargo for Targeted Anti-Angiogenesis in Squamous Cell Carcinoma

Favorite
W1130-09-066 - Novel Reverse Vaccination Strategy to Prevent Immunogenicity during Pompe Disease Replacement Therapy

Favorite
W1230-10-078 - Observations of Abuse Deterrent Poly (ethylene oxide) Polymer Tablets Guided by Compression Force and Speed

Favorite
W1230-08-061 - 3-O-ethyl-l-ascorbic Acid: Characterization and Rational Design of Topical Formulations

Favorite
W1030-07-055 - Oleic Acid-Grafted-Chitosan and Thermosensitive Copolymer Based Depot-in-Depot System for Controlled Delivery of Basal Insulin: Effect of Degree of Oleic Acid Substitution

Favorite
W1130-08-058 - Olmesartan Medoxomil Loaded PEGylated bilosomes for Enhanced Transdermal Delivery: In Vitro Characterization, Ex Vivo Permeation and Comprehensive In Vivo Assessment

Favorite
M1430-11-088 - On-Demand and Point-of-Care Printing of Tablets for Sustained Drug Delivery and Personalized Dosing

Favorite
W1030-08-057 - One-Step Self-Assembling Tacrolimus Nanomicelles as a Topical Treatment for Retinal Neovascularization

Favorite
T1230-08-064 - Ophthalmic Formulations Comprising Carboxyvinyl Polymer and Guar-Borate Gelling System Containing Natamycin Loaded PEGylated Nanolipid Carriers: Formulation Optimization, and In vitro Evaluations

Favorite
M1530-13-103 - Ophthalmic Topical Delivery of Carvedilol via Phospholipid Based Cationic Nanocarrier Leciplex

Favorite
W1130-11-083 - OPTICORE™: An Innovative Double-Layer and Two-Triggers Coating Technology to Target the Ileo-Colonic Region

Favorite
W1130-11-082 - OPTICORE™: Clinical Proof-of-Concept of Colonic-Targeted Capsules by Pharmaco-Scintigraphy Study in Healthy Human Subjects

Favorite
T1530-13-103 - OPTICORE™: Effect of an Isolation Layer on Accelerated Drug Release in Conditions Resembling the Ileo-Colonic Region of the Gastrointestinal Tract

Favorite
T1330-07-053 - Optimization and Characterization of In Situ Microparticles of Sucrose Acetate Isobutyrate for Sustained Release of Rivastigmine

Favorite
T1030-08-057 - Optimization of Co-solvent Freeze-Drying Method for the Encapsulation of Thiostrepton in Sterically Stabilized Micelles

Favorite
W0930-12-094 - Optimization of Dermal Flurbiprofen Nanosuspension using Design of Experiment (DoE): Development by Wet Milling

Favorite
M1030-09-070 - Optimization of Ibuprofen Delivery through Rat Skin from Traditional and Novel Nanoemulsion Formulations

Favorite
T1530-13-101 - Optimization of SHetA2 Suspension for the Prevention of Endometrial Cancer

Favorite
M1430-10-076 - Optimization of Sulfobutyl-Ether- β-Cyclodextrin Levels in Oral Formulation to Increase Bioavailability of Progesterone

Favorite
W0930-13-104 - Optimized MSn workflow for improved structure elucidation of pharmaceutically relevant extractables and leachables

Favorite
M1530-12-095 - Optimized Processing Conditions for a Solvent Based Enteric Coating System

Favorite
W1230-09-066 - Optimizing Spray Drying Process Conditions for the Production of a Trehalose/Leucine Formulation with Potential Application in Dry Powder Inhalation

Favorite
M1030-10-077 - Optimizing the Combinations of Polymer and Extrusion Parameters for 3D Printing

Favorite
M1030-08-058 - Oral Delivery of Teriparatide Using a Microemulsion System: Design, Characterization, In Vitro and In Vivo Evaluation

Favorite
W1030-13-104 - Orally Disintegrating Dosage Forms Using Radio Frequency Energy

Favorite
M0930-08-064 - Organogel in situ implants: a promising drug delivery system for therapeutic drugs

Favorite
W1230-13-103 - Orodispersible Films for Personalized Medicine–A Platform and Framework for Its Small-Scale Manufacture at Point-of-Care

Favorite
M1030-11-081 - Osmolyte Stabilized Protein Formulation for Enhanced Wound Healing Activity

Favorite
W1030-07-050 - Osmotic Pump Drug Delivery for Poorly Water-Soluble Drugs Using High Molecular Weight Hydroxyethyl Cellulose as an Osmopolymer

Favorite
W1130-11-081 - Osmotic-Rupturing Multiparticulates: A pH-independent Drug Delivery System Suitable for Delayed or Pulsatile Release Application

Favorite
M0930-13-101 - Over-the-Counter (OTC) Weight Loss Nutraceuticals: Label Claim, Microbiological, Pharmaceutical Quality and Safety Assessments

Favorite
T1430-07-050 - Paclitaxel and Erlotinib-Co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer

Favorite
T1530-11-081 - Paclitaxel-Loaded Nano-Liposomes Generated with Consistent Characteristics Using Proliposome Technology Along with High-Pressure Homogenization and Membrane Extrusion

Favorite
M1130-11-087 - Papain and Papain-Cyclodextrin Complex Loaded in Minitablets for Use in Ulcerative Processes and Absorption Enhancer: Complex Characterization and Manufacturing of Minitablets by Direct Compression

Favorite
M1130-08-063 - Paracellular Permeation-Enhancing Effect of Modified Fragments of Tight Junction Modulating Protein

Favorite
T1230-12-096 - Particle Formation of a Freeze-Dried Monoclonal Antibody

Favorite
T1330-13-099 - Passive Inhalation of Dry Powder Influenza Vaccine Formulations: A Feasible Method of Mass Vaccination that Completely Protects Chickens against Lethal Dose of Bird Flu Virus

Favorite
T0930-08-062 - Patient-Specific 3D Scanned and 3D Printed Biomedical Devices

Favorite
T1230-08-060 - Pazopanib Loaded PLGA Nanoparticles for Sustained Drug Delivery to Eye in Diabetic Retinopathy

Favorite
M1430-08-059 - PEG-PLA Polymersomes as Multidrug Nanocarriers for Intranasal Delivery of Therapeutics

Favorite
T1130-09-066 - PEGylated Aspartic Acid Modified Liposome as a Bone-Targeting Carrier for the Delivery of Paclitaxel and Treatment of Bone Metastasis

Favorite
M1330-13-103 - PEGylated Chitosan for Aerosol Delivery of CRISPR/Cas9 System

Favorite
M1330-08-061 - Penetration Ability, Cleansing and Antibacterial Effect of Chlorhexidine Hydrochloride Nanoemulsion as Root Canal Irrigant

Favorite
T1530-08-059 - Percutaneous Absorption and Skin Accumulation of Lorazepam, Diphenhydramine Hydrochloride and Haloperidol from Carbopol Gel

Favorite
M1530-07-049 - Performance Evaluation During Process Development::Different Techniques, Complementary Results

Favorite
W0930-10-080 - Performance of Mini-tablets containing various Lactose-based Excipients.

Favorite
M0930-07-053 - pH and Bicarbonate Molarity Effects on Dissolution of Enteric-Coated Dosage Forms

Favorite
T1030-11-084 - Pharmaceutical Multicomponent System–A New Type of Donepezil-Water-Maleic Acid Crystal and More

Favorite
T1130-12-095 - Pharmacokinetic and tolerability study of a novel 17β-estradiol and progesterone intravaginal ring in sheep

Favorite
W0930-09-072 - Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheep

Favorite
M1430-10-077 - Pharmacokinetics Study of Sorafenib Tablet (SYO-1644) with Improved Bioavailability in Beagle Dogs

Favorite
M1330-10-074 - Phase Behavior and Transformation Kinetics of a Poorly Water Soluble Weakly Basic Drug upon Transit from Low to High pH Conditions

Favorite
W1230-11-085 - Photochemically Stabilized Formulation of Dacarbazine with Reduced Production of Algogenic Photodegradants

Favorite
M1030-11-085 - Photo-Induced Tyrosine Side Chain Fragmentation in IgG4-Fc: Mechanisms and Effect of Glycosylation

Favorite
W0930-08-059 - pH-responsive Reversibly Activable Cell-penetrating Peptide-anchored Liposomes for Enhanced Tumor Delivery of Artemisinin

Favorite
M1130-08-061 - pH-Sensitive Nanogels Featuring Reversible Swelling by pH Circulation

Favorite
M0930-11-083 - Physical Properties of Novel Surfactant for Stabilization of Biologics Suggest Mechanism for Improved Performance

Favorite
M1430-07-053 - Physical, Mechanical, and Adhesive Characterization of Soluplus®/Vitamin E Films

Favorite
W1230-10-073 - Physical-Mechanical Evaluation of a Novel Co-processed Tableting Excipient, LubriToseTM Mannitol

Favorite
T0930-08-063 - Physico-chemical and Cell Viability studies of Chitosan/Alginate Microparticles Containing Mycobacterium smegmatis as a Model Mycobacteria Species

Favorite
T1530-08-061 - Physicochemical Properties of a Topical Film Forming Solution Containing Alcoholic Extract of Sahastara Remedy, a Thai Traditional Medicine, for Anti-Inflammation

Favorite
T1330-12-092 - Physiologically relevant in vitro-in vivo correlation (IVIVC) model for the development of sildenafil sustained-release formulation

Favorite
W0930-09-068 - Plateau Hypoxia Attenuates the Metabolic Activity of Intestinal Flora to Lessen the Bioavailability of Clopidogrel

Favorite
M0930-08-062 - Poloxamer-Based Thermosensitive Hydrogel System for Controlled-Release of IKV-741

Favorite
M0930-10-076 - Polymer-Solvent Interactions of Pharmaceutical Excipients for Spray Dried Dispersion

Favorite
M1530-10-074 - Polyvinyl Alcohol (PVA) in Amorphous Solid Dispersions - Understanding the Stabilizing Effect

Favorite
T1330-12-089 - Population pharmacokinetics in vitro-in vivo correalation (IVIVC) approach for the prediction of in vivo pharmacokinetics from formulation composition

Favorite
T1530-12-091 - Potassium Assay in OTC Drug Products by Ion Chromatography

Favorite
T1530-09-070 - Predicting Stability of Ternary Amorphous Solid Dispersion Using Specific Mechanical Energy Input From Hot Melt Extrusion

Favorite
M1530-07-056 - Prediction of Dissolution Profiles from Process Parameters, Formulation, and Spectroscopic Measurements

Favorite
W1130-10-073 - Preferential Drug Loss of Physically Manipulated Abuse-Deterrent (AD) Opioid Drug Products Prepared for Nasal Insufflation Studies

Favorite
W1130-09-068 - Pre-formulation Development of Stabilized Stem Flu Nano-particle Vaccine Candidate

Favorite
M1530-08-061 - Preformulation Studies and Development of Nanoemulgel of Ebselen for the Treatment of Topical Fungal Infection

Favorite
W1030-08-058 - Pregabalin Microemulsion Once Daily Eye Drops for Management of Glaucoma

Favorite
M1130-08-060 - Preparation and Characterization of a Reactive Oxygen Species (ROS)-Triggered Nano Delivery System containing Memantine and Celecoxib

Favorite
T1330-09-072 - Preparation and Characterization of Efavirenz Porous Solid Dispersions Using Pressurized CO2 via Hot Melt Extrusion

Favorite
M1330-08-058 - Preparation and Characterization of Pimozide Loaded Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles for Glioblastoma Targeted Delivery

Favorite
M1530-11-087 - Preparation and Characterization of Ternary Amorphous Solid Dispersion of a Highly Potent and Novel Anti-tubercular Indole-2-Carboxamide Derivative with Curcumin and Hydrophilic Polymers

Favorite
M0930-12-090 - Preparation and Characterization of Ternary Amorphous Solid Dispersions of Reservatrol, Dibenzoylmethane and, Curcumin with Hydrophilic Polymers for Enhancement of Aqueous Solubility and Stability

Favorite
W1230-07-049 - Preparation and Characterization of Various Formulations for Intranasal Delivery of Poorly Soluble Compound Dibenzoylmethane (DBM) for the Treatment of Neurodegenerative Diseases

Favorite
M1430-09-065 - Preparation and Evaluation of Celecoxib Ternary Solid Dispersion Granules Using Solvent Evaporation Based One-Pot Process

Favorite
M1530-13-100 - Preparation and Evaluation of Lipid-Based Formulations for Primaquine Delivery: A Comparison of Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsions (NE)

Favorite
T1530-10-073 - Preparation and Evaluation of Porous PLGA Microparticles Using Spray Drying Technique

Favorite
T0930-08-060 - Preparation and Evaluation of Valacyclovir Hydrochloride Ocular Inserts Prepared by Hot Melt Extrusion Techniques

Favorite
W1130-08-060 - Preparation and In Vitro Evaluation of Topical Pilocarpine Formulation for Stimulating Sweat Secretion for Cystic Fibrosis Diagnosis: An Alternative to Iontophoresis Technique

Favorite
M0930-12-095 - Preparation and In Vitro Release of Essential Oils Containing Medicated Chewing Gum Formulation for the Treatment of Oral Candidiasis

Favorite
M1330-10-080 - Preparation and lymphatic delivery evaluation of methotrexate-loaded nanoparticles

Favorite
T1330-10-073 - Preparation of Amide Salts Consisting of Acetaminophen and Sulfonic Acids and Its Relative Stability/Tablettability

Favorite
T1430-09-070 - Preparation of Cilostazol Cocrystals with Hydrxybenzoates by Spray Drying Method and Their Characterization

Favorite
T1030-08-061 - Preparation of Curcumin-Resveratrol and Curcumin-Quercetin Nanoparticles for Transdermal Delivery in the Prevention and Treatment of Melanoma

Favorite
M1130-10-074 - Preparation of Dual Targeted Release Formulation Using Hot Melt Extrusion Technology

Favorite
M1030-09-066 - Preparation of Hydrogel Transdermal Patch using Twin Screw Processor

Favorite
M1230-10-075 - Preparation of Itraconazole Amorphous Solid Dispersion and Evaluation In Vitro and Bioavailability In Vivo

Favorite
W1130-07-051 - Preparation of Repaglinide loaded Solid Lipid Nanoparticles by Microfluidization for Oral Delivery of Anti-diabetes Therapeutics

Favorite
M0930-08-058 - 3D-Printed Nanofilms for Sustained Drug Delivery

Favorite
T1230-09-070 - 3D Printed Systems for Colon Specific Drug Delivery Combining Fused Deposition Modelling and Injection Volume Filling

Favorite
M1430-11-085 - 3D Printing of Customizable Zero-Order Release Tablets

Favorite
T1330-11-086 - 3D Printing of Hot-Melt Extruded Clarithromycin Formulations Using Soluplus®︎ and Kolliphor®︎ P407

Favorite
M1230-11-087 - 3D Printing of Orally Disintegrating Tablets

Favorite
M1330-09-065 - Probing the Temperature-Dependence of Structural Relaxation Times Deep in the Glassy State of Amorphous Pharmaceuticals

Favorite
W1230-13-099 - Process and Formulation Effects on Protein Structure and Stability Using Solid State Hydrogen/Deuterium Exchange Mass Spectrometry (ssHDX-MS)

Favorite
M1030-10-076 - Producing Amorphous Solid Dispersions using Electrospraying

Favorite
T1130-09-068 - Protein Corona and Shear Stress Influence the Uptake of Clickable Gelatin-Oleic Nanoparticles for Cancer Targeting

Favorite
W0930-13-101 - Pur Q* Fused Quartz Vials for Enhanced Chemical Stability

Favorite
M1230-13-097 - PVA in Sustained Release Matrix Tablets–Wet Granulated vs Direct Compression

Favorite
W0930-07-053 - Quadrupole Dalton-Based Multiple Attribute Monitoring Method Combined with Rapid Trypsin Digestion for Characterization of Therapeutic Proteins

Favorite
T1130-11-082 - Qualitative Assessment of Silicone Oil and Protein Interactions

Favorite
M1030-12-092 - Quantification of MDMA in Ecstasy Tablets using Near-Infrared Spectroscopy and Partial Least Squares Regression

Favorite
T1030-11-082 - Quantifying Partial Phase Separation of Pharmaceutical Amorphous Solid Dispersions on the 50-nm Scale by Spin Diffusion Solid-State NMR

Favorite
M1230-07-054 - Quantitative Analysis of Peptide-Matrix Interactions in Lyophilized Solids Using Photolytic Labeling

Favorite
W1030-12-091 - Quickly determine protein stability through smart multivariate formulation DoE by assessing Aggregation Rate and Particle Size

Favorite
T1230-12-093 - Radiopacifier Additi